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1. INTRODUCTION 
                  Cancer is one of the dreadful diseases of 20
th
 century and moving vastly towards 
21
st
 century. According to the studies, worldwide about 6 million new incidences are reported 
every year. It is the second major cause of death after cardiovascular diseases.
[1] 
                 „Neoplasm‟ or tumor is a mass of tissue formed as a result of abnormal, excessive, 
uncoordinated, autonomous and purposeless proliferation of cells even after cessation of 
stimulus for growth which caused it.
 
                    The branch of science dealing with the study of neoplasms or tumours are called 
oncology (oncos= tumour, logos= study). Neoplasms may be a ‘benign’ when they are slow- 
growing and localised without causing much difficulty to the host, or ‘malignant’ when they 
proliferate rapidly, spread throughout the body and may eventually cause death of the host. 
The common term used for all malignant tumours is cancer. 
[2] 
1.1 HISTORY 
               The cancer is existing from all of our human history; the earliest written record of 
cancer is from 3000 BC by the Egyptian Edwin Smith papyrus who described about breast 
cancer. 
          The several types of cancer were described with Greek word „carcinos‟ (crab or 
cray fish) by Hippocrates between 460 BC and 370 BC. The Greek Celsus between 25 BC 
and 50 AD translated the term „carcinos‟ in to „cancer‟ (crab) in Latin term and 
recommended surgery as treatment.
[3] 
              In the 15
th
 to 17
th
 centuries doctors discovered the cause of the death by dissecting 
the bodies.
[4]
 With the help of microscope „cancer spread‟, metastasis was discovered by 
English surgeon Campbell De morgan between 1871 and 74. In the 19
th
 centuries, Marie 
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curie and Pierre curie discover radiation, was used for effective non- surgical treatment for 
cancer. 
              The first use of drugs to treat cancer in the early 20
th
 century was “Mustard gas” but 
its side effects, decreasing WBC count, was unacceptable. So, researchers looked for other 
substances and discovered „Mustine‟. Since then several drugs have been developed to treat 
cancer.
[5] 
1.2 CURRENT STATISTICS OF CANCER WORLDWIDE 
                Worldwide cancer incidence and mortality statistics are taken from the 
International Agency on Cancer GLOBAGAN database and the World Health Organisation, 
Global Health Observatory and the United Nations World Population Prospects report.
[6] 
 In 2008 approximately 12.7 million cancers were diagnosed (excluding non- 
melanoma skin cancers and other non- invasive cancers). In 2012, an 
estimated 14.1 million new cases of cancer occurred worldwide. More than 
half of cancers occurring are in less developed regions. 
 The four most common cancers occurring worldwide are prostate, bowel, 
female breast and lung cancer. These four cancers account for around 4 in 10 
of all cancers diagnosed worldwide. 
 In 2010 nearly 7.98 million people died with cancer. In 2012, estimated 8.1 
million people died from cancer worldwide. More than 6 in 10 cancer deaths 
worldwide occur in less developed regions of the world.
[7]
 
1.3 CANCER IN INDIA 
 Cancer rates in India are considerably lower than those in developed countries such as 
United States data from population based cancer registries in India show that the most 
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frequently reported cancer sites in males are lung, oesophagus, stomach, and larynx.  In 
females, cancers of the cervix, breast, ovary and oesophagus are the most commonly 
encountered.
[8] 
 India officially recorded over half a million deaths due to cancer in 2011-5.3 
lakhs    as against 5.24 lakhs in 2010 and 5.14 lakhs in 2009. 
 The estimated number of new cancers in India per year is about 7 lakhs and over 
3.5 lakhs people die of cancer each year. Cancer is the leading cause of death 
worldwide, accounting for 7.6 million deaths in 2008. 
 Breast, lung, liver, stomach, colon cancer cause the most cancer deaths each 
year. 
 Death from cancer worldwide are projected to continue rising with an estimated 
13.1 million deaths in 2030. 
 The risk of developing cancer generally increases with age and mass lifestyle 
changes occur in the developing world.
[5]
 
1.4 BREAST CANCER 
 Breast cancer is a malignant neoplasm of breast tissue, either in cells that line the 
ducts that carry milk to the nipples (ducts cancer) and/or in cells that line the lobules that 
involved in milk production (lobular cancer). Tumors of the female breast are common and 
clinically significant but rare in men.  
          Among the important benign tumors are fibroadenoma, phyllodes tumor 
(cystosarcomaphyllodes) and intraductal papilloma.  
          Carcinoma of the breast is an important malignant tumor which occurs as non –
invasive (carcinoma in-situ) and invasive cancer with its various morphological varieties.
[9]
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1.5 INCIDENCE OF BREAST CANCER  
 As per GLUBAGON data, the breast cancer in women in the US are most common, 
about 1 in 8 have chance of developing breast cancer in their lifetime, but in India the overall 
incidence is less than US, but it‟s not far behind, because in 2008 the incidence rate was 
182460 in US whereas 115251 new cases were diagnosed in India, it shows the cancer burden 
in India is almost reached about 2/3 of that of the US and is raising steadily. 
  Since cancer deaths is projected to continue rising with an estimated 13.1 million 
deaths in 2030, particularly breast cancer accounting for 23% incidence and 13.7% deaths 
worldwide and mortality rate is expected to increase in India as per GLOBAGAN 2008 
data.
[10] 
1.6 PREVENTION OF CANCER 
       In recent years, certain precautionary measures are advocated to prevent or reduce the 
occurrence of cancer. The most important among them from the biochemical perspective, are 
Antioxidants namely vitamin E, ß-carotene, vitamin C and selenium.  
         The anti-oxidants prevent the formation or detoxify the existing free radicals (free 
radicals are known to promote carcinogenesis). In addition antioxidants are stimulate immune 
system, and promote detoxification of various carcinogens. 
         In general, most of the vegetables and fruits are rich in antioxidants. Their increased 
consumption is advocated to prevent cancer.
[11] 
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1.7 ROLE OF FREE RADICALS IN CANCER 
         A free radical is defined as a molecule or a molecular species that contains one or more 
unpaired electrons, and is capable of independent existence (E. g) O2
-
, OH
-
, COO
-
 
 Reactive oxygen species are a type of unstable non-radical derivatives of O2 which 
do not contain unpaired electron and that easily react with other molecules in a cell (e. g) 
H2O2, 
1
O2. The term reactive oxygen species are used in broad sense to collectively represent 
free radicals and (non-free radicals which are extremely reactive) of biological system. 
1.7.1 SOURCES AND GENERATION OF FREE RADICALS 
The major sources responsible for the generation of free radicals may be considered under 
two categories 
1. Due to normal biological processes (or cellular metabolism). 
2. Due to environmental effects. 
Cellular metabolism 
 Leakage of electrons from the respiratory chain (ETC) 
 Production of H2O2 or O2
-
 by oxidase enzymes (e .g) Xanthine oxidase, 
NADPH oxidase). 
 Due to chain reactions of membrane lipid peroxidation. 
 During the synthesis of prostaglandins. 
 Production of nitric oxide from arginine. 
 During the course of phagocytosis (as a part of bacterial action). 
 In the oxidation of heme to bile pigments. 
 As a result of auto-oxidation e.g. metal ions [Fe2+, Cu2+]; ascorbic acid, 
glutathione, flavin coenzymes. 
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Environmental effects
[12] 
 As a result of drug metabolism e.g. paracetamol, halotahane, cytochrome P450 
related reactions. 
 Due to damages caused by ionizing radiations (e. g. X-rays) on tissues. 
 Photolysis of O2 by light. 
 Photoextitation of organic molecules. 
 Cigarette smoke contains free radicals, and trace metals that generate OH-. 
 Alcohol promote lipid peroxidation. 
1.7.2 FREE RADICALS MECHANISM INVOLVED IN CANCER PATHOGENESIS 
  Cancer development can be described by three stages: 
 Initiation 
 Promotion 
 Progression  
     ROS can act in all these stages of carcinogenesis which ultimately leads to cancer by 
following mechanisms. 
[13] 
a) Free radicals can damage DNA, and cause mutagenicity and cytotoxicity, and thus 
play a major role in carcinogenesis. 
b) It is believed that ROS can induce mutations, and inhibit DNA repair process, that 
results in inactivation of certain tumor suppressor genes leading to cancer. 
c) Further, free radicals promote biochemical and molecular changes for rapid growth 
of tumor cells.
[14]
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1.8 ANTIOXIDANTS 
          The term “antioxidants” refers to any molecule capable of stabilizing or deactivating 
free radicals before they attack cells.
[13]
A biological antioxidants may be defined as a 
substance (present in low concentration compared to an oxidizable substrate) that 
significantly delays or inhibits oxidation of a substrate.
[14] 
            Humans have evolved highly complex antioxidant systems (enzymatic and non-
enzymatic), which work synergistically, and in combination with each other to protect the 
cell and Organ systems of the body against free radical damage. The antioxidants can be 
either endogenous or exogenous in nature. They can be classified into three main categories: 
1) The first line defense antioxidants which include superoxide dismutase (SOD), 
catalase, glutathione reductase (GR), minerals like Se, Cu, Zn etc. 
2) The second line defense antioxidants which include glutathione (GSH), vitamin C, 
albumin, vitamin E, carotenoids, flavonoids etc. 
3) The third line defense antioxidants which include a complex group of enzymes such 
as Lipase, Protease, DNA repair enzymes etc. 
             Antioxidants stabilize polyunsaturated fatty acids in foods by reacting with free 
radicals, chelating metal ions and interrupting the propagation phase of lipid peroxidation. 
Some antioxidants can interact with other antioxidants regenerating their original properties; 
this mechanism is often referred to as the “antioxidants network”. 
             There is growing evidence to support a link between increased levels of ROS and 
disturbed activities of enzymatic and non-enzymatic antioxidants in diseases associated with 
aging. 
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1.9 FLAVONOIDS 
 These are a broad class of low molecular ubiquitous groups of plant metabolite and 
are an integral part of the human diet. Flavonoids are benzo-gamma-pyrone derivatives 
consisting of phenolic and pyrane rings and during metabolism hydroxyl groups are added, 
methylated, sulfated or glucorinated. 
              There is intense interest in flavonoids due to their antioxidant and chelating 
properties and their possible role in the prevention of chronic and age related diseases. 
               Flavonoids are present in food mainly as glycosides and polymers and these 
comprise a substantial fraction of dietary flavonoids. The biological properties of flavonoids 
are determined by the extent, nature, position of the substituents and the number of hydroxyl 
groups. 
              These factors also determined whether a flavonoid will act as an antioxidant or as a 
modulator of enzyme activity, or whether it possesses anti-mutagenic or cytotoxic properties. 
The most reported activity of flavonoids is their protection against oxidative stress. 
 Thus flavonoids can scavenge peroxyl radicals and are effective inhibitors of lipid 
peroxidation, and can chelate redox-active metals, thus prevent catalytic breakdown of 
hydrogen peroxide (Fenton chemistry).
[13] 
 
1.9.1BREAST CANCER AND FLAVONOIDS – A ROLE IN PREVENTION 
           Endogenous estrogens, such as 17ß-estrodiol (E2), are implicated in the development 
of breast cancer. The putative mechanisms by which estrogens exert the carcinogenic effects 
have been recognized to involve the redox cycling of estrogen metabolites and subsequent 
estrogen-DNA adduct formation as well as the estrogen receptor-dependent pathway of 
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estrogen-induced cell growth. The former mechanism is regulated by phase I enzymes, 
mainly cytochrome P450 (CYP) 1A1, 1A2, and 1B1. 
           Epidemiological studies suggest an inverse association between a higher intake of 
flavonoids and breast cancer risk. Flavonoids, which are widely distributed in plant kingdom, 
have been recently reported as candidate compound that can exert chemopreventive effects in 
estrogen-dependent or independent breast cancer. 
[15] 
            Some flavonoids have been reported as potent aromotase inhibitors. Substantial 
evidence supports the concept that estrogens be involved in mammary carcinomas. Estradiol, 
the most potent endogenous estrogen, is bio synthesized from androgens by the cytochrome 
P450 enzyme complex called aromatase. Inhibition of aromatase is an important approach for 
reducing growth stimulatory effects of estrogens in hormone – dependent breast cancer. 
Therefore, flavonoids could be considered potential agents against breast cancer through the 
inhibition of aromatase activity. 
[16] 
1.10 SIDE EFFECTS OF CONVENTIONAL CHEMOTHERAPHY 
[17] 
             Majority of the cytotoxic drugs have more profound effect on rapidly multiplying 
cells, because the most important target of action are the nucleic acids and their precursors 
and acid synthesis occurs during division, it causes following side effects. 
 Bone marrow depression  
 Lymphocytopenia 
 Oral cavity infection 
 Diarrhoea 
 Alopecia 
 Carcinogenicity 
 Teratogenicity 
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 Hyperuricemia 
 Oligozoospermia 
 Impotence in males 
 Immune depression 
1.11 ROLE OF MEDICINAL PLANTS  
          In both developed and developing countries, breast cancer is the most frequent cancer 
and most frequent cause of deaths. The report, by National Confidential Enquiry into Patient 
Outcome and Death (NCEPOD) have shown that more than 1 in 4 patients died from the side 
effect rather than from cancer and patients suffering from treatment related toxicity despite 
receiving other treatment to reduce chemotherapy side effects.  An another study discovered 
that breast cancer patients receiving chemotherapy, some parts of their brain, responsible for 
learning and memory was affected when compared to untreated patients. 
         In search of new agents to treat cancer with fewer or less side effects a number of 
medicinal plant has been evaluated, because in pharmacology several active ingredients are 
found from medicinal plants. Some of the successful and potential lead molecules isolated 
from medicinal plants are vincristine, vinblastine, taxol, campothecin and podophyllotoxin.  
         Since the medicinal plants have phytoconstituents, which protects the plants from 
oxidative damages and may have same role in humans. They have wide range of action such 
as antitumor, antiviral, antibacterial, antimutagenic etc. they may act in different stages of the 
development of malignant tumor by protecting the DNA from oxidative damages.  
         They inactivate carcinogen by inhibiting the expression of mutagenic genes, they also 
inactivate the enzymes charged with activating procarcinogens and activate the systems 
responsible for the detoxification of xenobiotics. It can also inhibit anti-apoptotic gene as 
well as activate apoptotic gene. 
[18] 
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1.12 KANCHANARA GUGGULU VATI  
 Kanchanar guggulu vati is also known as kancanara guggul is a polyherbal ayurvedic 
formulation is beneficial in hypothyroidism, PCOS, lipoma, weight loss, tumour, cancer, 
cysts,goiter, wounds, fistula, boils and skin disorders.
[19] 
          It is claimed to have anti-oxidant, anti-cancer activity since these activities have not 
been scientifically proved, I have undertaken this study to evaluate the anti-oxidant and anti-
cancer effect of Kanchanara guggulu vati (polyherbal formulation) by In-vitro methods.  
                                                                                                                        Aim and Objective 
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2. AIM AND OBJECTIVES OF THE STUDY 
  Preliminary phytochemical analysis of the polyherbal formulation “Kanchanara 
guggulu vati”. 
 To evaluate the antioxidant activity (DPPH method) of polyherbal formulation 
“Kanchanara guggulu vati”. 
 To evaluate the IC50 concentration of methanolic crude extract of   “Kanchanara 
guggulu vati” by in- vitro cytotoxicity method (MTT assay). 
 To isolate the flavonoid fraction from polyherbal formulation “Kanchanara 
guggulu vati” by column chromatography. 
 Characterization of isolated flavonoid fraction by FT-IR and GC-MS. 
 To evaluate the IC50 concentration of isolated flavonoid fraction of Kanchanara 
guggulu vati by in- vitro cytotoxicity method (MTT assay). 
 To determine the DNA fragmentation activity of isolated flavonoid fraction from 
“Kanchanara guggulu vati”. 
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3. REVIEW OF LITERATURE 
3.1 BREAST CANCER 
Breast cancer is a malignant neoplasm of breast tissue, either in cells that line the 
ducts that carry milk to the nipples (ducts cancer) and/or in cells that line the lobules that 
involved in milk production (lobular cancer). Breast cancer may be benign or malignant. 
Benign tumor is not life threatening and non-invasive but, malignant tumor is life threatening 
and invasive.
[9] 
3.2 GENERAL FEATURES AND CLASSIFICATION 
          Carcinoma of the breast arises from the ductal epithelium in 90% cases while the 
remaining 10% originate from the lobular epithelium, breast cancer occurs more often in left 
breast than the right. Presents different types of carcinoma of the breast as proposed in the 
WHO classification with some modification. The important morphological forms are as 
follows. 
A. NON-INVASIVE (IN SITU) CARCINOMA 
1. Intra ductal carcinoma 
2. Lobular carcinoma (in-situ) 
B. INVASIVE CARCINOMA 
1. Infiltrating (invasive) duct carcinoma-NOS (not otherwise specified) 
2. Infiltrating lobular carcinoma 
3. Medullary carcinoma 
4. Colloidal (mucinous) carcinoma 
5. Papillary carcinoma 
6. Tubular carcinoma 
7. Adenoid cystic 
8. Secretary (juvenile) carcinoma 
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9. Inflammatory carcinoma 
10. Carcinoma with metaplasia 
C. PAGET’S DISEASE OF THE NIPPLE 
3.2.1 NON-INVASIVE (IN SITU) CARCINOMA 
          In general, two types of non-invasive or in-situ carcinoma they are intra ductal 
carcinoma and lobular carcinoma (in-situ), are characterized histologically by presence of 
tumor cells within the ducts or lobules respectively without evidence of invasion. 
 3.2.2 INVASIVE CARCINOMA 
          Infiltrating duct carcinoma- NOS (not otherwise specified) is the classic breast cancer 
and is the most common histological pattern accounting for 70% cases of breast cancer. In 
fact, this is the pattern of cancer for which the terms ‘cancer’ and ‘carcinoma’ were first 
coined by Hippocrates. Clinically, majority of infiltrating duct carcinomas have a hard 
consistency due to dense collagenous stroma (scirrhous carcinoma). Retraction of the nipple 
and attachment of the tumor to underlying chest wall may be present. 
 
3.2.3 PAGET’S DISEASE OF THE NIPPLE 
 
           Paget’s disease ofthe nipple is an eczematoid of the nipple, often associated with an 
invasive or non-invasive ductal carcinoma of the underlying breast. Morphological features 
are the skin of the nipple and areola is crushed, fissured and ulcerated with oozing of 
serosanguineous fluid from the erosions. Histologically, the skin lesion is characterized by 
the presence of Paget’s cells singly or in small clusters in the epidermis. 
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Figure: 1 Types of breast cancer 
3.3 ETIOLOGY 
Age: These incidence rises throughout a women’s lifetime, peaking at the age of 75-80 years 
and then declining slightly thereafter.  Breast cancer is very rare in before the age of 25. 
Personal history: Women with atypical hyperplasia, lobular carcinoma in situ or ductal 
carcinoma in situ are more likely to develop invasive breast cancer. 
First-degree relatives with breast cancer: A family history of breast cancer in the mother, 
father, sister or daughter increases the risk of breast cancer and the risk is even stronger if the 
family member was diagnosed before the age of 50 years old and/or the with pre-menopausal 
breast cancer. 
BRCA1/BRCA2: Having mutations in BRCA1, a gene on chromosome 17 that controls cell 
growth or BRCA2, a gene on chromosome 13 that suppresses cell growth, are associated  
with a 40-80% increased risk of breast cancer. 
Menstrual history: ages at menarche and menopause: Women who have an early age at 
menarche (<12 years) have a 30% increased risk of breast cancer while those who have a late 
age at menopause (>60 years) will have a 20-50% increased risk of disease. 
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Breast density on mammogram: Women with higher breast density have a higher risk of 
breast cancer. 
Atypical Hyperplasia: A history of prior breast biopsies, especially if revealing atypical 
hyperplasia, increases the risk of invasive carcinoma. There is a smaller associated with 
proliferative breast changes without atypical hyperplasia. 
 Age at first live birth child: Women who experience a first a first full term pregnancy at the 
ages younger than 20 years have half of the re age of risk of nulliparous women or women 
over the age of 35 at their first birth. These associations are consistently observed for 
hormone receptor-positive breast cancer. 
Race/ Ethnicity: Non-Hispanic white women have the highest rates of breast cancer. 
However, women of African or non-Hispanic ancestry present at a more advanced stage and 
have an increased mortality rate. Social factors such as decreased access to health care and 
lower use of mammography may well contribute to these disparities, but biological 
differences also play an important role.  
Estrogen exposure: Women who have taken menopausal hormone therapy (estrogen + 
progestin for at least 5 years) have a 20% greater risk of developing breast cancer. 
Radiation Exposure: Radiation to the chest, whether due to cancer therapy, atomic bomb 
exposure, or nuclear accidents, results in a higher rate of breast cancer. The risk is greatest 
with exposure at young ages and with high radiation doses. 
Exercise: There is a probable small protective effect for women who are physically active. 
Breastfeeding:  The longer women breastfeed, the greater the reduction in risk. Lactation 
suppresses ovulation and may trigger terminal differentiation of luminal cells. The lower 
incidence of breast cancer in developing countries largely can be explained by the more 
frequent and longer nursing of infants. 
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3.4 SYMPTOMS OF BREAST CANCER
 [20] 
 A lump or area of thickened tissue in either breast 
 A change in the size or shape of the breast 
 Discharge from the either of the nipple (which may be streaked with blood) 
 A lump or swelling in either of the armpits 
 Dimpling on the skin of the breast 
 Pain in either of the breast or armpits not related to period 
 Pus formation and foul odour 
 Unusual loss of weight 
 
3.5 PATHOGENESIS 
 
                               Figure: 2 Pathogenesis of breast cancer 
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             The cells of breast tissue undergo abnormal proliferation and differentiation is due to 
some factors like, predisposing factors (gender, age and genetics), precipitating factors (diet, 
oral contraceptives and immune suppression) and etiology (unknown). It is lead to the 
following,
[21] 
 Genetic mutation of cellular DNA e.g.p53 (apoptotic protein), BRCA1& BRCA2 
(tumor suppressor protein), which leads to activation of oncogenes. Inactivation of 
tumor suppressor gene, which leads to proliferation and differentiation of cancer cells 
in the milk duct and growth of malignant tumor 
3.5.1 Growth of malignant tumor 
 Activate immunologic mechanism which releases B-lymphocytes and T-lymphocytes, 
natural killer cells leads to cancer cell death. 
 Release of growth factor which induce angiogenesis, supports tumor growth 
 Cancer cells destroy normal RBCs, decrease HB, and nail beds become pale. 
3.5.2 Rapid growth of malignant tumor 
 Change in size of breast. 
 Rapid multiplication of cancer cells, so the metabolism in the cancer cells will 
increase. 
 The normal cells will be shortage of nutrients leads to unusual loss of weight and 
fatigue. 
 Obstruct the milk duct cause rupture of it, so releases of inflammatory mediators such 
as bradykinin, prostaglandins cause transient vasoconstriction. 
 Compression of blood and lymphatic vessels leads to decease blood supply to breast 
tissue cause ischemia followed by necrosis. 
 Blood and lymph stasis increases the vascular permeability after vasodilatation; 
plasma fluid leak in to the tissues causes swelling. 
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 Swelling of breast tissue will compress the nerve endings produce pain and 
accumulate the fluid cells, cellular debris, live and dead lymphocytes will form PUS 
followed by tissue decay and foul odour will produce. 
 Cancer cells begin to spread locally via lymphatic vessels and form tumor in axillary 
lymph nodes and supra clavicular lymph nodes which are palpable, immovable, hard 
and painless nodes. 
3.5.3 Mutation of BRCA gene 
Those individuals inherit defects in the DNA and gene or mutation of genes like BRCA1, 
BRCA2 are having more chances to develop breast cancer. 
 BRCA1, it is a tumor suppressor gene, which produces a protein, called breast 
cancer type 1 susceptibility protein. The protein encoded by the BRCA1 gene 
combines with other tumor suppressors, DNA damage sensors, and signal 
transducer to form a large multi-subunit protein complex known as the BRCA1- 
associated genome surveillance complex (BASC). It is found in the cells of 
breast and other tissue, where it helps repair of DNA double strand break, or 
induce   Apoptosis. 
 BRCA2 is a tumor suppressor protein encoded by the BRCA2 gene. It is 
involved in the repair of chromosomal damage with an important role in the 
error- free repair of DNA double strand breaks. 
3.5.4 Suppression of apoptotic signals 
 P53 is a protein with molecular weight of 53 KDa. This protein is encoded by TP53 
gene and having tumor suppressing function.
[22 ,23, 24] 
 P53 can activate the repair protein to 
repair the damaged DNA, if fail to repair the damaged DNA, P53 can also arrest the cell 
cycle by holding at G1/S phase. It is also plays a major role in apoptosis, genomic instability, 
and inhibition of angiogenesis. In cancer, mutation occur at DNA Binding Domain (DBD) so 
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the ability of this protein to bind to its target DNA sequences is inhibited, and thus prevents 
transcriptional activation of these genes. 
 TNFα the primary role of TNF is in the regulation of immune cells. TNF was thought 
to be produced primarily by macrophages, but it is also by a broad variety of cell types 
including lymphoid cells, mast cells, endothelial cells, cardiac myocytes, adipose tissue, 
fibroblasts and neurons. TNF, being an endogenous pyrogen, is able to induce fever, 
apoptotic cell death, sepsis (through IL1 & IL6 production), cachexia, inflammationand to 
inhibit tumorigenesisand viral replication. Dysregulation of TNF production is associated at 
variety of human diseases including Alzhemier’s, cancer, major depression and inflammatory 
bowel disease (IBD). 
  TNF can bind to two receptors such as TNF-R1 and TNF- R2. TNF-R1 found in most 
tissues whereas TNF-R2 found only in immune cells. In its transducer mechanism three 
pathways are activated such as, a) Activation of NF-κ B, cell survival and proliferation, anti-
apoptotic factors are mediated, b) Activation of the MAPK pathways, c) activation of c-Jun 
N- terminal kinases (JNK) pathways which involved in cell proliferation and pro apoptotic. 
3.5.5 Over expression of anti-apoptotic gene 
      Bcl-2 (B cell lymphoma 2), and Bcl- XL are belong to the family of Bcl-2. Those are 
encoded by Bcl-2 gene. It plays a role in regulating apoptosis. The Bcl-2 gene has been 
involved in a number of cancers including melanoma, breast, prostate, chronic lymphocytic 
leukemia and lung carcinomas. It is also involves in conventional chemotherapy resistance. 
     In lymphoma, mutation at fourteenth and eighteenth place of chromosome in heavy chain 
of immunoglobulin, where the gene Bcl-2 fused, leading to transcription of excessive levels 
of Bcl-2. This deceases the propensity of these cells for undergoing apoptosis. 
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3.5.6 Expression of oxygen regulated protein 
 The 150-kd oxygen- regulated protein (ORP150) also called as hypoxia up- regulated 
protein 1 encoded by HYOUI gene. The protein encoded by this gene is thought to play an 
important role in protein folding and secretion in the ER. Since suppression of the protein is 
associated with accelerated apoptosis, it is also have an important cyto-protective role in 
tumors, especially in breast tumors, and thus it is associated with tumor invasiveness. When 
the subjected to the tumor environmental stress such as oxygen deprivation, it redirects 
biosynthetic pathway to express 150Kda protein to maintain the cell viability.
[25]
 
3.5.7 Role of interleukins 
            Interleukins are group of cytokines, produced by wide variety of body cells. Among 
family of interleukins, some plays a major role in breast cancer. 
 Interleukin 6 (IL-6) is an interleukin that acts as both a pro- inflammatory and anti- 
inflammatory cytokine. In humans, it is encoded by the IL6 gene. Interleukin-6 (IL-6) plays a 
primary role in breast cancer pathophysiology. When cancer cells exposed to IL-6 the 
resistance towards drug is increased. Up regulation of it cause the cells to metastasize to 
bone. Advanced or metastatic cancer patients have higher levels of IL-6 IN their blood. 
Hence there is an interest in developing anti-IL-6 agents as therapy against several of these 
diseases. 
 Interleukin 4(IL-4), is a cytokine that   induces differentiation of native helper T 
cells to Th2 cells. Upon activation by IL-4, Th-2 cells subsequently produce additional IL-4. 
It stimulates the activated B- cell and T- cell proliferation, and the differentiation B cells into 
Plasma Cells, and also induces B- cell class switching to IgE, and up-regulates MHC class II 
production. IL-4 decreases the production of Th1 cells, macrophages, IFN-gamma, and 
dendritic cell IL-12.
[26, 27] 
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3.6 BREAST CANCER STAGING AND TREATMENT 
3.6.1 STAGING 
           A staging system is used to classify the extent of disease based on the tumor size, 
location (e.g. ducts, lobules), involvement of lymph nodes and has spread to surrounding 
tissue (e.g. chest wall, skin of breast) or distant organs (e.g. lungs, liver, brain, bone).
[20] 
3.6.2 TREATMENT 
[28] 
            Based upon tumor size, location, involvement of lymph nodes and metastasis, risk and 
stages of the disease, appropriate treatment will be given. 
 
1. SURGERY (based on biopsy): It includes, 
Lumpectomy or breast – conserving surgery 
       - Removal of lump and surrounding tissues 
Mastectomy 
-Removal of all the breast tissues 
Preventive surgery, 
        -Prophylactic mastectomy for women at risk and prophylactic ovary removal to 
lower estrogen production in the body. 
2. RADIATION THERAPY 
It is used to destroy the remaining cancerous cells left behind after surgery. 
 External Beam Radiation, which is well tested, long lasting treatment option, 
 Internal Beam Radiation (implantation of radioactive seeds), which is recently 
developed, shorter treatment interval, focused to the affected area so low exposure   
but fewer adverse effects. 
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3. CHEMOTHERAPY. 
        It is a systemic therapy, used to either to shrink the tumor or to reduce the risk           
recurrence. For advantage- stage disease, it is destroy as several cancer as possible. These    
are the chemotherapy drugs approved by FDA for breast cancer, 
Alkylating agent: 
Nitrogen mustard  - Cyclophosphamide 
Antimetabolites: 
Folate antagonists  - Methotrexate 
Pyrimidine antagonists - 5-Flurouracil 
Taxanes   - Paclitaxel, Docetaxel 
Antibiotics   - Doxorubicin 
Others   - Capecitabine, Everolimus 
4. HORMONAL THERAPY 
 It is given for the patients with hormone receptor-positive cancers. It is used to 
reduce the amount of estrogen or block its action to reduce the risk of recurrence at 
the early stage of the disease and to shrink or slow down the growth of existing tumor 
at the advanced stage of the disease. 
Aromatase inhibitors - Latrazole, Anastrazole, Exemestane 
Selective estrogen  
Receptor modulators -  Tamoxifen, Tormifene 
Estrogen receptor  
Down regulators  - Fulvestran 
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3.7 DRUG PROFILE OF KANCHANARA GUGGULU VATI 
(Polyherbal formulation) 
3.7.1 COMPOSITION OF KANCHANARA GUGGULU VATI 
[29] 
       Kanchnar guggulu vati is an ayurvedic polyherbal formulation, consisting of 12 
medicinal plants. 
                    Table 1: Composition of ingredient(s) present in poly herbal formulation, 
           Kanchanara guggulu vati 
 
Botanical name 
 
Parts used 
 
Quantity (%) 
Bauhinia variegata Stem bark 24.10% 
Terminalia chebula Fruit 4.82% 
Terminalia bellerica Fruit 4.82% 
Emblica officinalis Fruit 4.82% 
Zingifer officinale Rhizome 2.41% 
Piper longum Dried  fruit 2.41% 
Piper nigrum Dried fruit 2.41% 
Crataeva nurvala Stem bark 2.41% 
Elettaria cardamomum Dried fruit 0.60% 
Cinnamomum zeylanicum Stem bark 0.60% 
Cinnamomum tamala Leaf 0.60% 
Commiphora weightii Oleo resin 50% 
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3.7.2 PROFILE OF INDIVIDUAL INGREDIENTS OF KANCHANARA     
GUGGULU VATI 
1. BAUHINIA VARIEGATA 
 BOTANICAL NAME :  Bauhinia variegata 
 FAMILY   :  Ceasalpiniaceae 
 PARTS USED  :  Stem bark 
 DISTRIBUTION  :  distributed throughout India, except  
                                      Jammu Kashmir, Himachal Pradesh, Sikkim  
VERNACULAR NAMES 
 Tamil       :    Sihappumandarai 
 English    :    Mountain Ebony 
 Hindi       :    Kachanaar, orhid tree 
 Telugu     :    Bodanta 
 Malayalam     :  Chovanna, mandaru 
PHARMACOLOGICAL ACTIVITY 
 The bark, flowers and root are used as a cataplasm 
 Root decoction used in dyspepsia 
 Flowers used as laxative 
 And bark used as tonic and anthelmintic 
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2. TERMINALIA CHEBULA 
BOTANICAL NAME :  Terminalia chebula 
FAMILY :  Combretaceae 
PARTS USED :  Fruit 
DISTRIBUTION :  Distributed throughout Southeast Asia- India, Southeast 
Asia- India, Srilanka, Bhutan, Nepal, Malaysia 
VERNACULAR NAME 
Tamil : Kadukaay 
English    :     Black or chebulicmerobalan 
Hindi        :     Haritaki 
Telugu       :       Nallakaraka 
Malayalam     :    Katukka 
PHARMACOLOGICAL ACTIVITY 
 Astringent 
 Bleeding  condition 
 Anti-bacterial 
 Anti-ulcer 
 Anthelmintic  
 Laxative 
 Stomachic and tonic 
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3. TERMINALIA BELLERICA 
BOTANICAL NAME  Terminalia bellerica 
FAMILY :  Combretaceae 
PARTS USED :  Fruit 
DISTRIBUTION & HABITAT :  Distributed throughout Indian Forests  and plains. 
VERNACULAR NAME 
Tamil : Tanri 
English :  Beach almond 
Hindi :  Bahuvirya 
Telugu :  Tandra 
Malayalam :  Thaanni 
PHARMACOLOGICAL ACTIVITY 
 The dried fruits used as astringent, tonic and laxative 
 Also used in piles, diarrhoea 
 Bark of the plant is used as to increase diuresis 
4. EMBLICA OFFICINALIS 
BOTANICAL NAME :  Emblica officinalis 
FAMILY :  Phyllanthaceae 
PARTS USED :  Fruit 
DISTRIBUTION :  Found throughout India, the sea coast districts and on hill 
Slopes upto 200 meters also cultivated in plains. 
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VERNACULAR NAMES 
Tamil :  Nelli 
English :  Amla, Indian gooseberry 
Hindi :  Aonla 
Telugu : Usiri 
Malayalam : Nelli 
PHARAMACOLOGICAL ACTIVITY 
 Fresh fruit is refrigerant, tonic, antiscorbutic, diuretic and laxative, blood purifier, 
diarrhea and jaundice 
 Syrup from the fruit is antibilous, diuretic and cooling; used in fever, vomiting, 
indigestion and habitual constipation 
 The root bark is used in aphthous stomatitis 
 The root is used in jaundice treatment, dyspepsia, and cough 
 The shoots are used in diarrhea, indigestion 
5. ZINGIBER OFFICINALE 
BOTANICAL NAME :  Zingiber officinale 
FAMILY :  Zingiberaceae 
PARTS USED :  Rhizome 
DISTRIBUTION :  Distributed in China, India, Indonesia, Nepal, Nigeria, 
and Thailand 
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VERNACULAR NAME 
Tamil :  Inji 
English :  Ginger 
Hindi : Adrak 
Telugu : Allam 
Malayalam : Inchi 
PHARMACOLOGICAL ACTIVITY 
 The rhizome is used as a stimulant, carminative 
 It is used in dyspepsia, vomiting, rheumatism, dysentery, cholera, piles 
 Also promotes menses in amenorrhoea 
6. PIPER LONGUM 
BOTANICAL NAME : Piper longum 
FAMILY : Piperaceae 
PARTS USED : Dried fruit 
DISTRIBUTION : Distributed in shady floors and village grove in India 
Found in Kerala, globally found in Indonesia, Madagaskar 
VERNACULAR NAME 
Tamil : Tippili 
English :  Long pepper 
Hindi : Pippal 
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PHARMACOLOGICAL ACTIVITY 
 Thermogenic, tonic 
 Diuretic, purgative 
 Expectorant, anorexia 
 Splenomegaly, aphrodisiac 
 Fever, digestive, and general debility 
 Bronchitis 
 Disease of spleen 
 Tumors  
7. PIPER NIGRUM 
BOTANICAL NAME : Piper nigrum 
FAMILY : Piperaceae 
PARTS USED : Dried fruit 
DISTRIBUTION : Native for black pepper is Malabar region of 
Southwestern India. Now it is grown in various tropical 
regions, including India, Indonesia and Brazil 
VERNACULAR NAMES 
Tamil : Karumilagu 
English : Black pepper 
Hindi : Mirch 
Telugu : Miryalatige 
Malayalam : Karumulaku 
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PHARMACOLOGICAL ACTIVITY 
 Dried unripe fruits are stimulant, carminative and stomachic 
 Also used as diuretic, and anti-diabetic agents 
8. CRATAEVA NURVALA 
BOTANICAL NAME : Crataeva nurvala 
FAMILY : Capparidaceae 
PARTS USED : Stem bark 
DISTRIBUTION : It is widespread from India to Southeast Asia, South of 
China 
VERNACULAR NAME  
Tamil : Maralingam 
English : Three hand capu 
Hindi : Baruna 
Telugu : Bilvarani 
Malayalam : Neermatalam 
PHARMACOLOGICAL ACTIVITY 
 Anticancer activity 
 Anti-urolithiasis 
 Migraine  
 Intestinal worms 
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9. ELETTARIA CARDAMOMUM 
BOTANICAL NAME : Elettaria cardamomum 
FAMILY : Zingiberaceae 
PARTS USED : Dried fruit 
DISTRIBUTION : Distributed in evergreen monsoon forests of the  western 
Ghatz in Southern India and western highland in Srilanka 
VERNACULAR NAMES 
Tamil : Elam, Elakkaai 
English : Cardamom 
Hindi : Chhoti Elachi 
Telugu :  Yelakayalu 
Malayalam : Elakkaya, Citalam 
PHARMACOLOGICAL ACTIVITY 
 Eases stomach pain 
 Carminative, aromatic 
 Anti-spasmodic 
 
10. CINNAMOMUM ZEYLANICUM 
BOTANICAL NAME : Cinnamomum zeylanicum 
FAMILY : Lauraceae 
PARTS USED : Stem bark 
DISTRIBUTION : Native is Indian subcontinent, Nebal, Bhutan, Pakistan 
but most specifically in Sri Lanka. Also found in Brazil, 
Madagaskar, Vietnam 
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VERNACULAR NAMES 
Tamil : Channalavangam 
English  Cinnamon 
Hindi : Dalchini 
Telugu : Dasini 
Malayalam : Elavangam 
PHARMACOLOGICAL ACTIVITY 
 Warming stimulant, carminative 
 Antispasmodic, anti-septic 
 Anti-viral 
11. CINNAMOMUM TAMALA 
BOTANICAL NAME : Cinnamomum tamala 
FAMILY : Lauraceae 
PARTS USED : Leaf 
DISTRIBUTION : Native is India, Nepalese cinnamon is Popular  for its 
medicinal properties 
VERNACULAR NAMES 
Tamil : Talishapattiri 
English : Indian bay leaf 
Hindi : Tejpatta 
Telugu : Tasilapatri 
Malayalam : Tamalapatram 
Drug Profile 
Institute of Pharmacology, MMC  34 
 
PHARMACOLOGICAL ACTIVITY 
 The leaves are used in the treatment of colic and diarrhea 
 Hypoglycemic activity 
 Anti-fungal activity 
12. COMMIPHORA WEIGHTII 
BOTANICAL NAME : Commiphora weightii 
FAMILY : Burseraceae 
PARTS USED : Exudate 
DISTRIBUTION : Guggul is native to India, Pakistan and Arabia in  India it 
is found in Rajastan, Gujarat, Madhya  Pradesh and 
Karnataka 
VERANACULAR NAME 
Tamil : Mahisaksiguggalu 
English : Indian badellium 
Hindi : Guggulu 
Telugu : Guggipannu 
Malayalam : Gulgulu 
PHARMACOLOGICAL ACTIVITY 
 Anti-bacterial 
 Paralysis 
 Rheumatoid arthritis 
 Gout 
 Anti-inflammatory 
 Anti-viral 
 Anti-fertility  
 Anti-obesity 
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3.8 PHARMACOLOGICAL STUDIES 
3.8.1 BAUHINIA VARIAGATA 
Amita Mishra et al. (2013), assessed the antibacterial, antioxidant, and anticancer 
activity of various leaf extracts of B. variagata. Acetone fraction exhibited appreciable 
reducing power at all the test concentration.  Benzene, ethyl acetate, and water extracts were 
similar with minor differences.  Water fraction was found to be the most active exhibiting 
percentage growth inhibition against prostrate, lungs (hop-62), ovary, Breast (mcf-7), cell 
lines respectively.  
Ethyl acetate extract showed marked cytotoxicity against mcf-7(84%), thp-(93%) cell 
lines. In general, breast (mcf-7) leukemia (thp-1) cell lines exhibited greater sensitivity to 
Bauhinia variegate extracts. 
[30] 
Sonam Pandey et al. (2012), evaluated the antioxidant and free radical scavenging 
activity of Bauhinia variagata by in-vitro methods. Among the various extracts methanol 
extracts showed good antioxidant activity. IC50 value of B. variagata leaf, stem bark and 
floral buds are 17.9, 19.5 and 17.2 µg/ml respectively.
[31] 
M.M.Ghiaisas, et al. (2008) evaluated the immuno modulatory activity of ethanolic 
extracts of the stem bark of B .variegata using swice albino mice. On oral administration, 
extract showed a significant increase in the primary and secondary humoral antibody 
responses, by increasing the hemagglutinating antibody titre at doses of 250 and 500 mg/kg 
there was a significant increase in the phagocytic index and percentage neutrophil adhesion at 
doses of 250 and 500 mg/kg. This study reveals that the B. variagata holds a promise as an 
immune modulatory agent, which acts by stimulating both the specific and non-specific arms 
of immunity.  
[32] 
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H. Bodakhe, et al, (2007), assessed the hepato protective properties of bark extract of 
Bauhinia variagata in CCl4 induced cirrhosis in male Sprague dawly rats.  Stem bark 
extracts at 200 mg/kg dose showed better anti-hepatotoxic activity. Hence, B.variegata 
appears to be a promising hepatoprotective agent. 
[33] 
SM. Bairagi et al. (2012), evaluated the anti-inflammatory activity of methanol and 
aqueous fraction of the bark of B.variegata by dextran induced edema method in albino rats.  
Anti-inflammatory activity determined by carrageenan induced paw edema and dextran 
induced paw edema. The anti-inflammatory activity determined by carrageenan induced paw 
edema were not too significantly different (P>0.05) from the control. Significant activity 
against dextran induced paw edema in rats was exhibited by both methanol extract (P<0.01) 
 and aqueous extract (P<0.05) when administered orally at 200 mg/kg. 
[34] 
3.8.2 TERMINALIA CHEBULA 
Kannan.P et al. (2009), evaluated the anti-bacterial activity of ethanolic fruit extract 
of T. chebula against clinically important standard reference bacterial strains. The fruit 
extract was highly effective against Salmonella typhi and the MIC was determined as 
1mg/ml.
[35] 
Rohini Ahuja et al. (2013), investigated the invivo and invitro anticancer activity of 
T. chebula fruits against ehrlich ascites cells in swiss mice. The high dose of ethanolic extract 
of T. chebula (200mg/kg, orally) significantly reduces the tumour growth which was 
demonstrated by increased lifespan of the mice and restoration of hematological parameters. 
ETC was also found to be cytotoxic in-vitro parameter which shows that ETC 
possesses significant anticancer potential. T. chebula against buffalo rat liver 3A, MCF-7, A -
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549 cell lines. The extracts was potent 1.7µg/ml, 643.13± 4.2µg/ml, 208.16± 3.7µg/ml, 
respectively. 
The extract showed the higher content of total phenolic and flavonoids was directly 
associated to higher cytotoxicity activity. The ethanolic leaf gall extracts of T. chebula 
showed effective cytotoxicity activity, which might be attributed to the phenolic / flavonoids 
present in higher concentration.
[36] 
Koteswara Rao et al. (2006), investigated the chloroform extract of T. chebula seed 
powder for its anti-diabetic activity in STZ induced diabetic rats using short term and long 
term study protocols. The efficacy of the extract was also evaluated for the protection of renal 
functions in diabetic rats. The chloroform extract of T. chebula seeds produced dose 
dependent reduction in blood glucose of diabetic rats when compared with the standard drug 
(Glibenclamide).  
In short term study the maximum reduction in blood glucose of 20.85%, (p<0.01), 
28.45% (p<0.001) and 42.20% (p<0.001) at four hours with doses of 100,200,300mg/kg 
respectively. In long term study (4 weeks) also it produce significant reduction in blood 
glucose. The maximum reduction in blood glucose of 53.09% (p<0.01), when compared with 
control glibenclamide 60.10% (p<0.01).
[37] 
Sarmistasaha et al. (2014), investigated the antioxidant activity of poly phenolic 
extract of T. chebula by various in vitro methods. The antioxidant activity of the extract is 
significantly higher than the standard ascorbic acid, and its activity is concentration 
dependent.
[38] 
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3.8.3 TERMINALIA BELLERICA 
Amal M.Saad et al. (2014), evaluated the antioxidant and cytotoxic effect of T. 
bellerica against HepG-2 cell line. The reducing power was ranged from (2.75 at 200µg/ml), 
with respect to the ascorbic acid (2.55). On the other hand, the results of HepG-2 assay 
showed that extract have cytotoxic activity with IC50 of 19.35µg/ml.
[39] 
Sharangouda J. Patil et al. (2010), evaluated the effect of T. bellerica bark various 
extracts on activities of accessory reproductive duct in male rats. Adult male rats were 
administered with 10mg, 25mg/100g of ethanolic and benzene extracts for 50 days showed 
decreased in the weight of accessory reproductive ducts and epididymal sperm count were 
significantly decreased. In conclusion, out of two extracts tested, ethanolic extract at the dose 
of level of 25mg/100g body weight is having more anti-spermatogenic and anti-steroidogenic 
activities in male rat reproductive system.
[40] 
M.C Sabu et al. (2008), evaluated the effect of continuous administration of 
methanolic extract of fruits of T. bellerica in alloxan induced hyperglycemia and antioxidant 
mechanism in rats. T. bellerica prevented alloxan induced hyperglycemia from the 6
th
 day of 
administration and there was 54% reduction on 12
th
 day (p<0.001). Similarly there was 
significant increase in the activity of catalase in blood and liver. These results suggested that 
T. bellerica fruit extract possessed anti-diabetic and anti-oxidant activity and these activities 
may be interrelated.
[41] 
RenuKadian et al. (2014), evaluated the antipsychotic potential of T. bellerica in 
experimental animal models. The fruit powder administered the concentration of (4%w/w, 
6%w/w, 8%w/w) for 15 consecutive days. Further, the biochemical estimation were done by 
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estimating brain dopamine levels. And it showed TBFP significantly decreased the dopamine 
levels. The results suggest that TBFP possesses anti-psychotic activity.
[42] 
3.8.4 EMBLICA OFFICINALIS 
SatishK.verma et al. (2012), evaluated the cytotoxic activity of Emblica officinalis 
whole plant extract against various cell lines namely of lung cancer (A-549), liver (Hep-2), 
colon (502713HT-29) and neuroblastoma (IMR-32). The activity was done using 100µg/ml 
of the extract against lung (A-549) cell line showed 82% of growth inhibition. In case of liver 
(Hep-2) showed no activity reported, where as in case of colon 502713 cell line plant extract 
showed maximum activity and  for neuroblastoma ( IMR-32) Cell line showed 97% growth 
inhibition.
[43] 
Gupta priya et al. (2012), evaluated the antimicrobial and antioxidant activity of 
seed extract of E. officinalis and the study concludes that seed extract contain high anti-
bacterial and antioxidant property.
[44] 
MahaveerGolechha et al. (2014), investigated the anti- inflammatory activity of 
hydroalcoholic extract of E. officinalis in rodent models of acute and chronic inflammation. 
The extract was administered at the dose of 300,500,700mg/kg. At the dose of 700mg/kg the 
extract shows maximum anti-inflammatory activity in all experimental models, and the 
effects were comparable to that of the standard anti-inflammatory drugs.
[45] 
Bheemshetty et al. (2015), evaluated the effect of ethanolic extract of E.officinalis on 
histopathology of kidney and on biochemical parameters in hyperlipidemic albino wistar rats. 
The ethanolic extract administered as the dose of 100mg/kg body weight daily, and the test 
dose treated hyperlipidemic animal model expressed changes in renal markers, biochemical 
parameters and histopathology of kidney.
[46] 
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3.8.5 ZINGIBER OFFICINALE 
Nalbantsoy et al. (2008), evaluated the antimicrobial and cytotoxic activities of 
ethanol and chloroform extracts of Z. officinale. The cytotoxic activity investigated against 
Hela (Human Cervical Cancer) and mouse fibroblast (L929) cell lines. The antibacterial 
activity was tested by the paper disc diffusion technique. IC50 values versus mouse fibroblast 
and Hela cells were found to be 7.28µg/ml and 74.32µg/ml, respectively, for the chloroform 
extract, while the ethanol extract showed IC50 values at 101µg/ml and 33.78µg/ml, 
respectively. 
The antimicrobial activity results showed that the ginger extracts inhibited the growth 
of 5 out of 8 microorganisms but had no effect on the growth of E.coli, Pseudomonas 
aeroginosa and Stephylococcus epidermidis.
[47] 
Silvia Mosovska et al. (2015), evaluated the antioxidant activity of ginger extract. A 
method for the extract was chosen, which enabled to isolate mostly phenolic compounds 
(181.41mg/g of extract) from which flavonoids contributed to 7.8% (14.15mg/g of extract). 
NMR analysis showed that the phenolic ketones were predominant in the extracts of whole 
phenolic compounds. According to results of two spectrophotometric methods (ABTS& 
DPPH test), ginger extract showed stronger ability to scavange DPPH radical than ABTS 
cation radical.
[48] 
ShafinaHanimmohd Habib et al. (2005), evaluated the anticancer and anti- 
inflammatory effects of ginger extracts on Ethaionine induced hepatoma in rats. Ginger 
extracts significantly reduced the elevated expression of NFκb through the suppression of the 
pro-inflammatory TNF-α.[49] 
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P.Paul et al. (2012), evaluated the hypolipidemic effect of ginger extract in vanaspati 
fed rats. The extract consequently administered (300mg/100ml/g. body weight/day) orally for 
49 day. Simultaneous administration of ginger extract significantly (p<0.05) prevented the 
rise in total cholesterol, LDL, triglyceride level and rise HDL. In histo pathological study, no 
significant changes were found in the liver and aorta of all the treated groups as compared 
with control group. It is concluded that ginger extract showed hypolipidemic effect in 
vanaspati fed rats.
[50] 
S.S Prasad et al. (2012), investigated the action of ginger-juice on blood coagulation 
process in rat. Chronic administration of ginger- juice (2ml& 4ml. p.o for 30 days) caused an 
increase in the bleeding time.
[51] 
3.8.6 PIPER LONGUM 
Beena Joy. (2010), studied the antioxidant, anticancer, and antimicrobial activity of 
various fruit extracts of Piper longum. For antioxidant activity, out of the different extracts 
tested, the ethyl acetate extract and cold hexane: water extracts (1:1) showed better 
antioxidant activity. The screening of antimicrobial and antitumor effects of Piper longum 
showed the better efficacy of those two extracts. The antitumor studies showed a dose 
dependent behavior of the extracts towards leukemic cell lines K562. Among the three 
bacteria tested, hot ethyl acetate extract showed more potency against E.coli than Bacillus 
subtitlis and was found to be less active for staphylococcus aurus. The antioxidant, antitumor, 
and anti-microbial activity found to be higher for hot extracts than cold extracts.
[52] 
Archana.D et al. (2015), evaluated the antioxidant anti-clastogenic potential of 
methanolic extract of P.longum. The GC-MS analysis provides different peaks determining 
the presence of eighteen phytochemical compounds with different therapeutic activities. The 
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methanol extract at a concentration of 40µg/ml showed the highest antioxidant activity by 
DPPH assay (64.42%) comparable to standard, ascorbic acid (73.68%). The reducing power 
observed was in the order of 40µg/ml>20µg/ml>10µg/ml.  
The production afforded by extract against the cytotoxicity of peripheral blood 
lymphocytes were confirmed by micronucleus (MN) assay and the methanolic extract 
treatment decreased the frequency of MN in a concentration dependent manner.
[53] 
Alok S Wakade et al. (2008), investigated the effect of methanolic extract of fruits of 
P.longum on the biochemical changes, tissue peroxidase damage and abnormal antioxidant 
levels in Adriamycin induced cardio toxicity in Wistar rats. Chronic oral administration of 
methanolic fruit extract 250mg/g and 500mg/kg prevented Adriamycin induced alterations in 
marker enzyme activity, endogenous antioxidant levels and cellular damage (p<0.05).
[54] 
Shaik Abdul Nabi et al. (2013), evaluated the antidiabetic and antihyperlipidemic 
activity of P.longum root extracts in STZ induced diabetic rats. Among the different extracts 
were tested for their glucose lowering effects, the methanolic and aqueous extracts at a 
dosage of 200mg/kg produced maximum fall of 39% and 75% respectively, in the FBG levels 
of diabetic rats after 6 h of treatment. The administration of same dose for 30 days in diabetic 
rat resulted in a significant decrease in FBG levels in the corrections of diabetic dyslipidemia 
compared to untreated diabetic rats (p<0.1).
[55] 
3.8.7 PIPER NIGRUM 
Somchai Sriwiriyajan et al. (2015), investigated the anticancer and cancer 
prevention effects of piperine- free P.nigrum extract against breast cancer cell line and N- 
nitrosomethylurea induced mammary tumorigenesis in rats. The extract was a highly 
effective against the MCF-7 with IC50 value of 7.45µg/ml and showed lower values for the 
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other cell lines. And the tumor size of the treated group extract at the dose of 100, 200 and 
400mg/kg was significantly reduced when compared with the control and vehicle groups.
 [56] 
FarhanaTasleem et al. (2014), evaluated the analgesic and anti-inflammatory 
activities of hexane and ethanol extract of P.nigrum fruit in mice and rats. Piperine at a dose 
of 5mg/kg and ethanol extract at a dose of 15mg/kg after 120 min and hexane extract at a 
dose of 10mg/kg after 60 min exhibited significant (P<0.05) analgesic activity. In the 
evaluation of anti-inflammatory effect, piperine at a dose of 10 and 15mg/kg started 
producing anti-inflammatory effect after 30 min, which lasted till 60 min, whereas hexane 
and ethanol extract also produced a similar activity at a slightly low dose (10mg/kg) but 
lasted for 120 min.
 [57] 
Amin F. Majhalawieh et al. (2009), investigated the immunomodulatory and 
anticancer effect of P.nigrum and cardamom by in-vitro methods. The results showed that the 
black pepper and cardamom aqueous extracts significantly enhance splenocyte proliferation 
sin a dose dependent, synergistic fashion (P<0.01). Experimental evidence suggest that the 
extracts exert pro- inflammatory and anti- inflammatory roles, and it significantly enhance 
the cytotoxic activity of natural killer cell, indicating their potential anti-cancer effects.
[58] 
Md. Gayasuddin et al. (2013), investigated the effect of ethanolic extract of 
P.nigrum fruits on midazolam induced hypnosis in rats. Study result showed that sub chronic 
treatment of 100mg/kg of extract p.o for five consecutive days on hypnotic dose (50mg/kg) 
of midazolam in rats significantly increased the sleeping time in pretreated group to 35% to 
that of control value without affecting the sleeping latency.
[59] 
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3.8.8 CRATAEVA NURVALA 
Swati N.Hade et al. (2016), evaluated the antioxidant, anti-proteolytic, and cytotoxic 
effects of stem bark extract of C.nurvala against hepato-carcinoma and mouse melanoma cell 
lines. Among different extract the methanolic extract showed better radical scavenging 
activity.  The extract showed good proteolytic activity with 26.04% inhibition on BSA and 
the IC50 values stem bark extract against HepG2 and B16F0 cells using MTT were 
determined to be 34.67µg/ml, and 49.43µg/ml after 48 h, respectively. 
[60] 
AtanuBhattacharjee et al. (2014), investigated the antioxidant and anti-demantia 
activities of Crataeva nurvala stem bark extract against scopolamine induced cognitive 
impairment via antioxidant activities in rats. Sub-acute exposures (daily, for 7 successive 
days) of stem extract (100, 200, and 400 mg/kg) significantly increased antioxidant enzyme 
activities (SOD and CAT), total content of reduced GSH and reduced lipid peroxidation 
(MDA level) in rat brain homogenates in dose dependent manner, suggesting the antioxidant 
potential. Moreover, the Hebb’s William maze test, the extract showed significant 
improvement in transfer latency, suggesting anti-demantia activity.
[61] 
Bhaskar et al. (2009), evaluated the anti-fertility activity of stem bark extract of C. 
nurvala in rats. The ethanol and aqueous extracts exhibited partial and complete resorption of 
implants at 300 and 600 mg/kg dose levels, respectively. In estrogenic activity study, both the 
extracts increased uterine weight and caused opening and cornification of vagina in immature 
rats. The present study justifies its effectiveness in preventing pregnancy in all rats at dose 
level of 300 and 600mg/kg.
[62] 
SikarwarMukesh S et al. (2012), investigated the antihyperlipidemic activity of 
Crataeva nurvala stem bark extracts in triton and atherogenic diet-induced heperlipidemic rat 
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model. Among various extracts, oral administration of 500 mg/kg of the ethanolic extract and 
aqueous extract exhibited reduction (p0.01) in serum lipid parameters like total cholesterol, 
triglycerides, LDL, VLDL, and increase in HDL in hyperlipidemic rats in comparison with 
hyperlipidemic control in both model.
 [63] 
3.8.9 ELETTARIA CARDAMOMUM 
Samir Qiblawi et al. (2012), evaluated the chemo preventive effect of cardamom on 
chemically induced skin carcinogenesis in swiss albino mice. A significant reduction in the 
values of tumor incidence, tumor burden, and tumor yield of papillomas was observed in 
mice treated orally with 0.5 mg of cardamom powder in suspension continuously at pre-, 
peri-, post-initiational stages of papillomagenesis compared with the control group. 
Treatment of cardamom suspension by oral gavage for 15 days resulted in a significant 
decrease in the lipid peroxidation level of the liver (P<0.1).  
In addition, the reduced glutathione level was significantly elevated in comparison 
with the control group (P<0.5) following cardamom suspension treatment. Taken together, 
these findings indicate the potential of cardamom as a chemo preventive agent against two-
stage skin cancer.
[64] 
SweetyKumari et al. (2013), studied the protective effect of E. cardamomom against 
pan masala induced damage in lung of male swiss mice. Lung of pan masala treated group 
showed adenocarcinoma, edema, and inflammation with increased activity of acid 
phosphatase, alkaline phosphatase, and lactate dehydrogenase. The deleterious effects were 
seen to be less in cardamom treated group and the enzymatic activity also decreased 
significantly (P<0.05) in the ameliorating group.
[65] 
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BheenaKhillare et al. (2014), evaluated the spermicidal activity of cardamom and 
cumin seed extracts in albino rats. Under the test conditions, minimum effective 
concentrations for cardamom and cumin seeds extract are 1mg/million sperm and 
5mg/million sperm respectively. The sperm was also studied for their morphology and 
viability of sperm was also studied and no change was observed in morphology of head, mid-
piece and tail and no viable sperm seen. 
[66] 
Jamal.A et al. (2005), investigated the anti-ulcerogenic activity of Elletaria 
cardamommum and Amomum subulatum in albino rats. Results obtained from experimental 
model of ethanol induced acute ulcer in rats showed 76.36% protection when 50mg/kg 
essential oils of cardamom, in case of oils of A. subulatum it was 60.91% inhibition. Thus, it 
is concluded that cardamom is more potent in inhibiting gastric ulcer than A. subulatum.
[67] 
3.8.10. CINNAMOMUM ZEYLANICUM 
B.Varalaxmi et al. (2013), evaluated the antimicrobial and anticancer activities of 
C.zeylanicum bark extracts against Hep G2 cell line. Among the various extract the 
methanolic extract showed an IC50 value of 150µg/ml against HepG2 MTT assay. In 
antimicrobial results also showed the methanolic extract had better antibacterial and 
antifungal activity. The extract showed MIC value of 2.5mg/ml for Bacillus subtilis and 
5mg/ml for Aspergillus niger. 
[68] 
UlkuGulchihanSimsek et al. (2013), evaluated the antioxidant activity of cinnamon 
bark oil (Cinnamon zeylanicum L.) in Japanese quails under thermo neutral and heat stressed 
conditions. Cinnamon oil supplementation to diet significantly increased antioxidant enzyme 
activity and GSH level of the tissues in both environmental conditions (P<0.01). Dose of 500 
ppm cinnamon oil had strong effect on antioxidant activity of the internal organs (P<0.01). In 
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conclusion, cinnamon oil supplementation to diet reduced the adverse effects of heat stress 
and resulted the protective effect on the internal organs by activating antioxidant mechanism. 
[69] 
PaulinNyadjeu et al. (2011), evaluated the antihypertensive and vasorelaxant effects 
C. zeylanicum stem bark aqueous extract in rats. The extract at a dose of 5, 10, 20 mg/kg 
induced a significant reduction in mean blood pressure in salt-loaded hypertensive, and 
spontaneously hypertensive rats in dose dependent manner.
[70] 
Kalpana Joshi et al. (2009), investigated the anti-inflammatory activity of C. 
zeylanicum by in-vitro and in- vivo methods. Both the methods were targeting TNF-α using 
flow cytometry. Ethanol extract showed suppression of intracellular release of TNF-α in 
murine neutrophils as well as leukocytes in plural fluid. The extract was found to be inhibit 
TNF-α gene expression in LPS- stimulated human PBMCs at 20µg/ml concentration. [71] 
3.8.11. CINNAMOMUM TAMALA 
DurreShahwar et al. (2015), evaluated the anticancer activity of C. tamala towards 
human ovarian cancer cells. The leaf extract were isolated through spectroscopic method, 
among four isolated compounds, no: 1 exhibited highest cytotoxicity with 90.16±1.06% 
inhibition followed by compound 2 with 84.40±1.53% inhibition, while compounds 3 and 4 
were inactive in the bioassay.
[72] 
S Lashmi Devi et al. (2007), evaluated the antioxidant activity of C. tamala using 
brain synaptosomes of diabetic rats as model system. Methanolic leaf extracts contains 6.7mg 
gallic acid /100g, and it displayed scavenging activity against superoxide and hydroxyl 
radicals in a concentration dependent manner. Maximum inhibition of lipid peroxidation, 
scavenging activity, and reducing power of leaf extract were observed at a concentration of 
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220µg. These effects of leaf extract were comparable with that of BHT a synthetic 
antioxidant.
[73] 
RupeshSoni et al. (2013), evaluated the effect of ethanolic extract of C. tamala 
leaves on wound healing in STZ induced diabetic rats. In the excision wound model the 
wound area and day of epithelization both were significantly decreased in ethanolic extract 
treated rats. In incision wound model the significantly higher tensile strength was observed in 
rats treated orally (100mg/kg) with ethanolic extract. The results suggested that the ethanolic 
leaf extract can be used in treatment of delayed wound healing in diabetic rats.
[74] 
Manoj K Dalai et al. (2013), investigated the acetyl cholinesterase (AchE) and butyl 
cholinesterase (BchE) inhibitory activity of the extract of C. tamala. The outcome of the 
study demonstrated that the cinnamon oil obtained from the leaves of C.tamala possesses 
maximum inhibition against AchE (IC50= 94.54µg/ml) and BchE (IC50=135µg/ml). Hence, 
this plant may be explored as anti-cholinesterase agent further for the better and safer 
management of Alzhemier’s diseases.[75] 
3.8.12COMMIPHORA WIGHTII 
Michelle xiao et al. (2012), revealed that Guggulu is having multi targeted chemo 
preventive and chemotherapeutic property by a review article. This study showed that 
guggulu is mainly active against prostate cancer cell line because it contains number of 
steroids, including two isomers Z-and E-guggulusterone. The IC50 1µmol/L against PC-3 cell 
line. The guggulu mediated suppression of cancer cell proliferation has also been reported in 
human breast cancer cells, head and neck cancer cells, leukemia cells, lung cancer cells, skin 
cancer cells, and colon cancer cells.
[76] 
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Qureshi Ikram et al. (2014), evaluated the antioxidant activity of Commiphora 
wightii by various methods like anti-lipid peroxidation assay, metal chelating activity, DNA 
damage inhibition. In all these method guggulu extract exhibit good scavenging activity with 
the IC50 value=934µg/ml.
[77] 
Monika singh et al. (2013), investigated the antifungal activity of ethanolic extract 
C.wightii against various pathogenic fungi. The results showed that there was an increase in 
concentrations the rate of growth inhibition also increases. Further shows that the growth of 
these fungi inhibits more in presence of higher concentrations as compared to lower 
concentrations of extract.
[78] 
Sumitkumar et al. (2016), evaluated the anti-ulcer activity of aqueous extract of 
C.wightii by using indomethacin and ethanol induced gastric model in rats. Percentage ulcer 
inhibition of aqueous extract at 500mg/kg for indomethacin and ethanol induced ulcer model 
were 23.27%, 40.55% respectively, when comparing with standard drugs ranitidine and 
misoprostol.
[79] 
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3.9. REFERENCE FOR METHODOLOGY 
3.9.1. PHYTOCHEMICAL ANALYSIS 
Prathima Shetty et al. (2013), assessed the preliminary phytochemical screenig of 
ethanolic extract of Elettaria cardamomum fruits. In the study, the ethanolic extract showed 
the presence of alkaloids, saponins, flavonoids, tannins and phenolic compounds, terpinoids, 
and phytosterols, fixed oils, carbohydrates and protein.
[80] 
Veena Sharma et al. (2013), assessed the phytochemical investigation of leaves and 
stems of Achyranthus aspera Linn. Results revealed that both stem and leaves possesses the 
phytochemicals like alkaloids, terpenoids, flavonoids, cardiac- glycosides, saponins in 
different amount.
[81] 
3.9.2ANTIOXIDANT ACTIVITY 
M. Ragavendra et al. (2013), investigated the antioxidant activity of methanolic 
leafy extracts from six edible leafy vegetables. The methanolic extracts were studied for 
antioxidant activity by various method including DPPH method by using ascorbic acid as 
standard.
[82] 
Y. Lu et al. (2014), determined the antioxidant activity of citronellal and extracts of 
Cymbogon citratus by three different methods, including DPPH method, FRAP assay, and ß-
carotene bleaching assay.
[83] 
F.Pourmorad et al. (2006), carried out a systemic record of the relative antioxidant 
activity (DPPH) in selected Iranian medicinal plant species extracts, and also determined the 
total phenolic and flavonoid content by spectrometric methods.
[84] 
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3.9.3. MTT ASSAY 
Ali Abdullah et al. (2012), studied the cytotoxicity effect of methanolic extract of 
Fenugreek whole plant and investigated the mechanism involved in its growth-inhibitory 
effect on MCF-7 human breast cancer cells. The percentage cell viability was calculated 
based on absorbance read in ELISA reader at 570 nm.
[85] 
Vidhya and Devaraj et al. (2011), reported the anti –proliferative action of eugenol 
treated MCF-7 cell lines by MTT assay. The percentage of cell viability was calculated based 
on absorbance read in ELISA reader at 570nm. 
[86] 
Vidhyalakshmi et al. (2012), investigated the anti-cancer activities of two 
polysaccharides produced by Bacillus species and Pseudomonas species against MCF-7 cell 
line and viable cells were determined by the absorbance at 570nm with reference to 
655nm.
[87] 
3.9.4. DNA FRAGMENTATION 
Vidhyalakshmi et al. (2012), investigated the apoptosis of human breast cancer cells 
(MCF-7) induced by polysaccharides produced by bacteria and the result of DNA 
fragmentation was confirmed by DNA ladder assay.
[88] 
Vidhya and Devaraj et al. (2011), studied the induction of apoptosis by eugenol in 
human breast cancer cells. Used various staining technique for observe apoptosis such as 
giemsa stain for morphological alteration, fluorescence microscopy analysis of cells using 
acridine orange and ethidium bromide and quantification of DNA fragments. The cell 
shrinkage, membrane blebbing and apoptotic body formation were observed and reported. 
[89] 
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Khaghani et al. (2011), studied the induction of apoptosis in Hibiscus sabdariffa 
treated MCF-7 cell line. The pattern of DNA cleavage as sign of apoptosis was analyzed 
using a DNA ladder kit by agarose gel electroporosis method.
[90]
 
3.9.5. COLUMN CHROMATOGRAPHY AND TLC 
Bharathisampantham et al. (2016), isolated the flavonoid fraction from Trigonella 
foenum-graecum leaves extract. The isolated compound were subjected to TLC, FT-IR, 
1
H 
NMR, 
13
C NMR, mass spectroscopy for their characterization. And then free radical 
scavenging activity was studied for the isolated flavonoid quercetin compound.
[91] 
Kumuthavalli et al. (2010), isolated the ellagic acid from Terminalia bellerica by 
column chromatography and characterized the isolated compound on the basis of TLC, IR 
and GC-MS studies. And for the isolated compound anti-cancer activity was studied against 
DMBA induced papilloma in rats.
[92] 
Li –jing Lin et al. (2016), isolated and identified the flavonoid components from 
Pteris vittata L. plant extract, and the isolated components were characterized by thin layer 
chromatography, and NMR studies.
[93] 
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5. MATERIALS AND METHODS 
5.1 PLACE OF STUDY 
                Phytochemical evaluation, anti-oxidant activity, column chromatography studies 
are carried out in ARMATS research institute, Maduvangarai, Guindy, Chennai. 
                MTT assay, DNA fragmentation studies are carried out in LIFETECK research 
center, Arumbakkam, Chennai. 
                IR, GC-MASS studies are carried out in IIT University, Chennai. 
5.2 INSTRUMENTS USED 
 Column chromatography 
 UV-spectrophotometer 
 Heating condenser 
 FT-IR spectrophotometer 
 GC-MS analyzer 
 Microscope 
 Gel electrophoresis 
 Co2 incubator 
5.3 PREPARATION OF TEST SAMPLE EXTRACT 
                Kanchanara guggulu vati is an ayurvedic poly herbal formulation, which was 
purchased from Sarvayush Ayurvedic medicals, Arumbakkam, Chennai. 
Direct extraction  
           Direct extraction with methanol solvent following the method of Eloff, 1998 was used 
as extraction method, finely grounded kanchanara guggulu (poly herbal formulation tablets) 
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powder was extracted with methanol in the ratio of 1:10 in conical flask in shaking condition 
for overnight. The extract was filtered through the Whatmann No: 1 filter paper in a separate 
container. The process was repeated three times with the same test sample but using fresh 
solvent. The solvent was removed by placing the extracts in condensation process at 45ºc 
temperature. The extracted residue were weighed and re-dissolved in methanol solvent to 
yield 10mg/ml solution and the solution was ready for further analysis. 
5.4 PHYTOCHEMICAL ANALYSIS
[80, 81] 
The following tests were carried out for analyze the phyto-chemicals such as 
alkaloids, carbohydrates, phenolic compounds, flavonoids, saponins, fixed oils and steroids  
present in the methanolic crude extract of Kanchanara guggulu vati. 
Test for alkaloids: 
           A small portion of the extract was stirred separately with a few drops of dilute 
hydrochloric acid and filtered. The filtrate was tested carefully with various alkaloid reagents 
such as, 
1. Mayer’s reagent             -    cream precipitate  
2. Dragendroff’s reagent    -     brown precipate 
Test for carbohydrates: 
            The small amount of extract was dissolved in 5ml of distilled water and filtered. The 
filtrate was subjected to carry out the following tests, 
1. Molish’s test:  The filtrate was treated with 2-3 drops of 1% alcoholic α-napthol and 
2ml of concentrated sulphuric acid was added along the sides of the test tube. Brown 
ring formation between the layers indicates the presence of carbohydrates. 
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2. Fehling’s test:The filtrate was treated with 1ml of fehling’s solution and heated. 
Orange precipitate indicates the presence of carbohydrates. 
Test for glycoside: 
             The small amount of extract was hydrolyzed with hydrochlroric acid for few hours in 
a water bath and the hydrolates was subjected to Legal’s test. 
Legal’s test:  Hydrolates was added to with chloroform and the chloroform was then 
separated. To this equal quantity of dilute ammonia was added. Purple colour in ammonical 
layer indicates the presence of glycoside. 
Test for phenol and tannins: 
         A small quantity of extract was dissolved in water then ferric chloride solution was 
added the presence of blue or green colour indicates the presence of phenolic acids. 
Test for flavonoids: 
A small amount of extract was dissolved in 1ml of distilled water. 0.5 ml of dilute ammonia 
solution was added to it. Concentrated sulphuric acid was added later. A yellow colour 
indicated the presence of flavonoids. The yellow colour disappeared on allowing the solution 
to stand. 
Test for saponins: 
        A small amount of extract was dissolved in 5ml of distilled water and shaken vigorously 
till a stable persistent froth was obtained. The froth was mixed with 3 drops of olive oil and 
shaken vigorously and then observed for emulsion. 
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Test for terpinoids: 
Alkaline reagent test: A small amount of extract was treated with few drops of sodium 
hydroxide solution and observed for intense yellow colouration which disappeared on the 
addition of dilute Hcl.  
Test for lactones: 
       The extracts treated with sodium picrate solution shows the appearance of yellow to 
orange colour which indicates the presence of lactone ring. 
Test for proteins: 
       2ml of Biuret reagent was added to 2ml of extract. It was shaken well and warmed on 
water bath. Appearance of red or violet colour indicates the presence of proteins. 
Test for fixed oils and fatty acid: 
Spot test:   Prepared spot on the filter paper with the test solution and oil staining on the filter 
paper indicated that the presence of fixed oil & fats. 
Test for steroids: 
Libermann Buchard test:  The solution of 1ml was treated with few drops of acetic 
anhydride, boiled and cooled, concentrated sulphuric acid was added from the sides of the 
test tube and observed for a brown ring at the junction of the two layers and green layer in 
upper layer. 
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5.5 EVALUATION OF ANTIOXIDANT ACTIVITY 
[82,83,84] 
 The radical scavenging activity of methanolic crude extract was determined by using 
DPPH assay according to Chang et al., (2008) with small modification. 
 The stock solution of extracts were made prepared in methanol to achieve the 
concentration of 1mg/ml. 
 Dilutions were made to obtain concentrations of 20µg, 40µg, 60µg, 80µg, 100µg, and 
120µg/ml. 
 Diluted solutions (1 ml each) were mixed with 1 ml methanolic solutions of DPPH in 
concentration of 1 mg/ml. 
 After 30 min incubation in darkness at room temperature, the absorbance was 
recorded at 517nm using spectrophotometer. 
 Reference compound being used was ascorbic acid and experiment was done on 
triplicate. 
 Control cuvette contained all the reagents except the test sample extract. 
 Percentage inhibition was calculated using equation 1, whilst IC50 values were 
estimated from the % inhibition versus concentration plot, using non-linear regression 
algorithm. 
 The data were presented as mean values ± standard error mean (n=3). 
 
% of DPPH radical scavenging activity (%RSA)   = Abs. control – Abs. sample × 100 
      Abs. control 
Abs. control is the absorbance of DPPH radical + solvent 
 
Abs. sample is the absorbance of DPPH radical + test sample. 
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5.6 IN-VITRO STUDIES 
MTT ASSAY FOR METHANOLIC CRUDE EXTRACT OF KANCHANARA 
GUGGULU VATI 
[85,86,87] 
          The anticancer activity of Kanchanara guggulu was evaluated by MTT assay against 
Breast cancer cell line (MCF-7). 
          It is a universally accepted in- vitro method for screening the drugs having cytotoxicity 
activity.  It was described by Mosmann (1983) & Monks (1991). This assay is used to 
determine the IC50 of drugs or extracts (concentration of drugs required to inhibit 50% cell 
growth). 
Materials required 
 Bio safety cabinet  
 UV-chamber 
 CO2 incubator 
 Inverted microscope 
 96 well micro titre plate 
 Fully grown/ confluency reached cell in culture flask 
 Minimum essential medium with 10% FBS 
 TPVG solution 
 Test drug extract (methanolic  extract) 
 DMSO solution (0.1% v/v) 
 Aluminium foil 
 Micropipette 
 Reagent bottle 
 Trypan blue 
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 MTT Invitrogen 
 Penicillin/streptomycin (250 U/ml) 
 Gentamycin (100µg/ml) 
 Amphotericin B (1 mg/ml) 
 Acridine orange 
MTT (3-[4, 5-dimethylthiazole-2-yl]-2, 5-diphenyl tetrazolium bromide) was obtained 
from Sigma, USA. All other fine chemicals were obtained from Sigma-Aldrich, St. 
Louis. 
Cell line and cell culture 
 The Human Breast Cancer Cell line, MCF-7 was obtained from NCCS 
(National Centre for Cell Science) Pune. 
 MCF-7 cells obtained from NCCS were cultured in Rose Well Park Memorial 
Institute medium (RPMI), supplemented with 10% fetal bovine serum, 
penicillin/streptomycin (250U/ml), gentamycin (100µg/ml) and amphotericin 
B (1 mg/ml).  
 All cell cultures were maintained at 37ºc, 5% CO2, 95% air and 100% relative 
humidity.  Maintenance cultures were passages weekly and the culture 
medium was changed twice a week. 
Cell treatment procedure 
 The monolayer cells detached with trypsin-ethylene diamine tetra acetic acid 
(EDTA) to make single cell suspension and viable cells were counted using a 
hemocytometer and diluted with medium containing 5% FBS to give final 
density of 1×10
5
 cells/ml. 
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 One hundred microlitres per well of cell suspension were seeded into 96- 
wellplates at plating density of 10,000 cells/well and incubated to allow for cell 
attachment at 37ºc, 5% CO2, 95% air and 100% relative humidity. 
 After 24 h the cells were treated with serial concentration of the samples. They 
were initially dissolved in neat dimethylsulfoxide (DMSO) and an aliquot of 
the sample solution was diluted to twice the desired final maximum test 
concentration with serum free medium. 
 Additionally seven serial dilution were made to provide a total of eight sample 
concentrations. Aliquots of 100µl of these different sample dilutions were 
added to the appropriate wells already containing 100µl of medium, resulting 
in the required final sample concentrations. Following sample addition, the 
plates were incubated for an additional 48 h at 37ºc, 5% CO2, 95% air and 
100% relative humidity. The medium containing without samples were served 
as control and triplicate was maintained for all concentrations. 
Principle 
The Tetrazolium salt, 3-(4, 5-dimethyl thiazole-2-yl)-2, 5, diphenyl tetrazolium 
bromide is reduced into formazan product by the mitochondrial dehydrogenase enzyme of 
live or metabolically active cells. The intensity of blue colored formazan produced is directly 
proportional to the cell viability.
[92] 
Procedure 
 Cells (1× 105/well) were plated in 24- well plates and incubated in 37ºc with 
5% CO2 condition. After the cell reaches the conditions, the different 
concentrations (7.8, 15.6, 31.2, 62.5, 125, 250, 500, 1000µg/ml) of the test 
sample and standard 5-fluorouracil were added and incubated for 24 hrs. 
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 After incubation, the sample was removed from the well and washed with 
phosphate- buffered saline (p
H
 7.4) or MEM without serum. 
 100µl /well (5mg/ml) of 0.5% MTT was added and incubated for 4 hours. 
After incubation, 1 ml of DMSO was added in all the wells and the absorbance 
at 570nm was measured with UV- spectrophotometer using DMSO as blank. 
 Measurements were performed and the concentration required for a 50% 
inhibition (IC50) was determined graphically. The % cell viability was 
calculated using the following formula: 
 
Percentage cell viability = A570 of treated cells / A570 of Control Cells ×100 
 
Graphs are plotted using the % cell viability at Y- axis and concentration of the 
sample in X-axis. Cell control and sample control is included in each assay to 
compare the full cell viability assessments. 
5.7 COLUMN CHROMATOGRAPHY 
[89, 90, 91] 
 Column chromatography is an isolation technique in which the phytoconstituents are 
being eluted by adsorption. 
            Russian botanist Mikhail Tswet invented column chromatography in 1906 as a means 
of studying plant pigments, but it soon became clear that the technique provided a means for 
separating many complex homogenous mixture into their individual components.
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PRINCIPLE 
              The principle involved in this separation of constituents is adsorption at the 
interface between stationary phase and mobile phase. The component which is having lower 
affinity towards stationary phase will elute first, and component having higher affinity 
towards stationary phase eluted last. No two compounds are alike in the above aspect.
[93] 
5.7.1 ISOLATION OF FLAVONOID FRACTION BY COLUMN 
CHROMATOGRAPHY 
Materials required 
 Analytical column (3cm diameter ×75cm ht) 
 15 ml Test tubes (Borosilicate) 
 Beaker (50ml) 
 China dish 
 Glass rod 
 Micropipette 
 TLC plate 
 Cotton 
 Test tube stand 
 Iodine chamber 
 UV chamber 
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Stationary phase 
       The most commonly used stationary phase for column chromatography is silica gel, 
alumina. Here, silica gel G (100-200 mesh size) was used as a stationary phase. 
Mobile phase 
      The mobile phase or eluent is either a pure solvent or a mixture of a solvent used to elute 
the mixture of components from the complex mixture. Based on the extract nature, solubility, 
and polarity, the following solvents were used; 
 Hexane 
 Ethyl acetate 
 Methanol 
Slurry preparation method 
Wet packing method 
 The column was filled about one third with hexane 
 The measured amount of silica gel was taken in a separate beaker, and it was mixed 
with hexane (one and half times the volume of silica) by using a glass rod to get the 
slurry. 
 The slurry was slowly poured in to the column by tapping the column gently to 
encourage bubbles to rise and the silica to settle, then solvent allowed to drain to 
prevent overflowing. 
 The slurry was continuously transfer to the column until all the silica was added. 
After that, the column was rinsed by draining the solvent at the edge. 
 The solvent fully drained until the solvent level was just even with the surface of the 
stationary phase.  
Materials and Methods 
Institute of Pharmacology  65 
 
Column running procedure 
 The methanol extract was subjected to silica gel column chromatography for the 
isolation of the flavonoids fraction. 
 Since the methanolic extract was found to possess significant pharmacological 
activity when compared to other extracts an attempt was made to fractionate the 
methanol extract by column chromatography. 
 The elution was done by using solvents of different polarity like hexane, ethyl acetate, 
and methanol. 
 An appropriate column sized 5cm diameter and 50cm length was used. It was washed 
with water and rinsed with acetone and then dried completely.  
 Little pure cotton was placed at the bottom of column up to ¾  level. Methanol extract 
was mixed with equal amount of graded silica gel until it became free flowing 
powder. 
 When it reached the defined state it was slowly poured in to the column containing 
hexane solvent with slight movement of stirring by glass rod avoid clogging. 
 Little cotton was placed on top of silica gel- extract mixture to get neat column pack. 
The knob at the bottom was slowly opened to release the solvent. 
 The elution was done using hexane, ethyl acetate, and methanol in different ratios like 
hexane (100%), ethyl acetate (100%), ethyl acetate: methanol (50:50) and methanol 
(100%). 
 As soon as the fractions were eluted, it was analyzed by using readymade TLC plate 
with suitable solvent system according to the polarity of elute. 
 All the fractions were tested for the presence of flavonoids by comparing with the 
standard quercetin solution by using TLC system and the developed chromatogram 
was observed under UV at shorter wavelength, and Rf value was calcualated. 
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5.7.2 CHARACTERIZATION OF ISOLATED FLAVONOID FRACTION  
1. THIN LAYER CHROMATOGRAPHY 
Principle 
           Thin layer chromatography is based on adsorption principle in which separation 
depends on the selective adsorption of the components of a mixture on the surface of solid. 
The stationary phase was in the form of a thin layer adhering to a suitable form of backing 
material over which the mobile phase was allowed to ascend by capillary action. 
Traditionally analytical TLC has found application in the detection and monitoring of 
compound through a separation process.
[94] 
Materials required 
 Readymade TLC plate (stationary phase) 
 Beaker 50 ml 
 China dish 
 Micropipette 
 UV chamber 
 Iodine chamber 
Solvent system used 
1. Methanol : ethyl acetate (1 :1) 
2. Toluene : ethyl acetate : methanol (1:0.5:0.5) 
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Procedure 
 Solvent system methanol: ethyl acetate (1:1), and toluene: ethyl acetate: methanol 
(1:0.5:0.5) were prepared and kept aside for saturation. 
 Readymade pre coated TLC plates were used, in which the backing material may be 
either of aluminum foil or a solvent resistant polyester sheet. These sheets are cut into 
desired size and used for the further analysis. 
 Then with the help of micropipette extracts was spotted on TLC plates, which were 
developed in solvent system tank (TLC chamber). 
 The developed chromatogram was observed under UV and it was photographed. 
 using the following formula, 
 
             Rf        = Distant travelled by the solute 
                         Distant travelled by the solvent front 
2.SPECTRAL STUDIES  
IR spectroscopy 
         Infra –red spectrum of the fraction obtained from the column chromatography of the 
ethyl acetate methanolic extract kanchanara guggulu, was subjected for its characteristic 
functional groups.  
              Instrument used   : Perkin Elmer FT-IR  
              Method                 : Neat spectra 
              Wave number       : 4000-450cm
-1
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GC-MS Spectroscopy 
           GC-MS spectrum of the fraction obtained from the column chromatography of the 
ethyl acetate methanolic extract was investigated for its purity and molecular weight to 
characterized the fraction by its mass and mass of fragments. 
5.8MTT ASSAY FOR ISOLATED FLAVONOID FRACTION OF KANCHANARA      
GUGGULU VATI 
[85, 86, 87] 
            The fraction obtained from the column chromatography of the ethyl acetate 
methanolic extract was identified as its containing flavonoid fraction (Quercetin) by 
characterization studies such as TLC, IR spectroscopy and GC-MS, so the sample was 
investigated for its cytotoxity activity against MCF-7 cell line.  
Cell line 
              The Human Breast Cancer cell line, MCF-7 was obtained from the NCCS, Pune. 
Procedure 
 Cells (1× 105/well) were plated in 24- well plates and incubated in 37ºc with 
5% CO2 condition. After the cell reaches the conditions, the different 
concentrations (7.8, 15.6, 31.2, 62.5, 125, 250, 500, 1000µg/ml) of the test 
sample was added and incubated for 24 hrs.  
 After incubation, the sample was removed from the well and washed with 
phosphate- buffered saline (p
H
 7.4) or MEM without serum. 
 100µl /well (5mg/ml) of 0.5% MTT was added and incubated for 4 hours. 
After incubation, 1 ml of DMSO was added in all the wells and the absorbance 
at 570nm was measured with UV- spectrophotometer using DMSO as blank. 
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 Measurements were performed and the concentration required for a 50% 
inhibition (IC50) was determined graphically. The % cell viability was 
calculated using the following formula: 
 Percentage cell viability = A570 of treated cells / A570 of Control Cells ×100 
Graphs are plotted using the % cell viability at Y- axis and concentration of the 
sample in X-axis. Cell control and sample control is included in each assay to 
compare the full cell viability assessments. 
5.9 DNA FRAGMENTATION STUDY
[86, 87, 88] 
           This study was carried out to determine the DNA fragmenting ability of both flavonoid 
fraction and 5- fluorouracil. From the both standard and test sample treated and untreated 
cells, DNA were extracted using Genei TRIsoln reagent. The supernatant obtained at end of 
the extraction contained DNA were quantified and observed the fragmentation by 1.2% 
agarose gel electrophoresis method. 
Agarose gel electrophoresis method 
           Electrophoresis is a technique of separating substances based on the size of the 
molecule under the influence of an electric field. Bigger molecules moves slowly whereas, 
smaller molecules move faster. 
           Agarose gel electrophoresis is a method of separating DNA using flexible gel like 
slab, under the influence of electric field. It is widely using method for the analysis of nucleic 
acid and proteins. 
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Materials required 
 Agarose 
 TTE buffer 
 Bromophenol blue dye 
 10X loading buffer 
 DNA ladder 
 Extracted DNA  
 Electrophoresis chamber 
 Gel casting tray and comb 
 Conical flask 
 Sterile tips and pipette 
 Microwave oven 
 Centrifuge  
 Power supply 
Procedure 
i) Agarose gel preparation 
 The gel casting tray and comb were wiped with ethanol and dried it. To 
form a mould, two ends of the tray were sealed using tape. 
 Weighed 1.2 g of agarose powder and transferred to 500 ml conical flask. 
Added 100 ml of TTE buffer to the flask, heated the slurry in microwave 
oven until agarose dissolved and the solution became clear. 
 Using insulated gloves the flask was transferred in to a water bath at 55ºc 
to cool the molten gel. 
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 The gel casting tray kept on the table horizontally, the comb was placed at 
one end of the tray. 
 Then cooled gel solution poured into a mould slowly to avoid bubble 
formation and allowed it to cool for 30 minutes. 
 Removed the tapes from both the ends and placed the tray in the 
electrophoresis chamber, which was connected with positive and negative 
electrode, the comb was taken out carefully and added TTE buffer until it 
covered the gel surface. 
ii) Sample loading 
 Based on quantification done by Nano Drop apparatus, placed equal 
quantity of DNA, obtained from control, test sample extract and standard 
treated cells, on a piece of parafilm and added enough TTE buffer to made 
up the total volume of 10µl each. 
 2µl of 10X loading dye placed near to the drop of DNA sample and mixed 
both thoroughly. 
 Slowly load 10µg/ml 100bp DNA ladder and 12µl of sample mixtures into 
the wells of submerge gel successively. 
iii) Running the gel 
 Covered the gel tank with lid, turned on power supply and set about 80 
volts. 
 Allowed the DNA to turn until the bromophenol blue dye migrated near to 
end of the gel. 
 After that turned off the power supply, removed the lid, the gel tray had 
taken out carefully 
 The gel was placed inside the UV transilluminator to visualize the DNA.  
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6. RESULTS 
6.1 PHYTOCHEMICAL SCREENING: 
            The Phyto-chemical analysis of methanolic crude extracts of kanchanara guggulu vati    
(Polyherbal formulation) are presented in Table 2. 
Table 2: Phyto-chemical analysis 
 
S.no 
 
Phytoconstituents 
 
Inference 
1 Alkaloids Present 
2 Tannins and Phenolic compounds Present 
3 Terpinoids Present 
4 Saponins Present 
5 Flavonoids Present 
6 Glycosides Absent 
7 Carbohydrates Present 
8 Lactones Absent 
9 Proteins Present 
10 Fixed oils and fatty acid Present 
11 Steroids Present 
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6.2 ANTIOXIDANT ACTIVITY 
             Antioxidant activity (DPPH method) of ascorbic acid and methanolic crude extract of 
Kanchanara guggulu as shown in Table 3. and figure 3. 
 
Table 3:  IC50 value and Percentage inhibition of ascorbic acid and MCEKG 
 
S 
.no 
 
Concentration 
(µg/ml) 
 
Percentage 
inhibition of 
(std) 
Ascorbic acid 
IC50 value 
(µg/ml) 
 
Percentage 
inhibition 
Of MCEKG 
IC50 
(µg/ml) 
1 20 32.663 ± 0.308 
35.37 
12.213 ± 0.119 
70.98 
2 40 51.653 ± 0.253 28.227 ± 0.225 
3 60 65.530 ±0.285 49.093 ± 0.147 
4 80 78.573 ± 0.286 52.503 ± 0.208 
5 100 87.303 ± 0.339 61.380 ± 0.208 
6 120 90.247 ± 0.326 68.090 ± 0.191 
 
All values are expressed as mean ± SEM for triplicates values 
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                          Figure:  3   Percentage inhibition of ascorbic acid Vs MCEKG 
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6.3 MTT ASSAY 
       The MTT assay were conducted using 5-Fluorouracil and the methanolic crude extracts 
of Kanchanara guggulu and the results are presented in Table 4 & 5 and Figures 4-7. 
 
Table 4: IC50 value and percentage cell viability of 5- FU 
S No. 
Concentration 
(µg/ml) 
Absorbance 
Cell Viability 
(%) 
IC 50 (µg/ml) 
1 1000 0.096 10.24±0.476 
15.96 
2 500 0.167 17.52±0.265 
3 250 0.225 23.58±0.175 
4 125 0.300 31.70±0.312 
5 62.5 0.370 38.69±0.353 
6 31.2 0.388 40.57±0.337 
7 15.6 0.473 49.46±0.380 
8 7.8 0.545 57.22±0.289 
9 Cell Control 0.954 99.99±0.090 
 
All values are expressed as mean ± SEM for triplicates values 
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                       Figure 4. Graphical representation of concentration dependent cell 
                                        Inhibition of 5-flurouracil 
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Fig. 5a Normal MCF 7 Cell line 
Anti Cancer Effect of 5-FU on MCF-7 Cell line 
 
              
 
 
 
 
  
Fig. 5bCytotoxicity - 1000µg/ml   Fig.5cCytotoxicity – 15.6µg/ml  
 
 
 
            Fig. 5dCytotoxicity – 7.8 µg/ml 
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                Table 5: IC50 value and Percentage cell viability of MCEKG 
 
S.no 
 
Concentration 
(µg/ml) 
 
Absorbance 
 
Cell viability (%) 
 
IC50 value (µg/ml) 
1 1000 0.09 15.233 ± 0.044 
 
55.26 
 
 
2 500 0.13 21.976 ± 0.039 
3 250 0.17 28.720 ± 0.165 
4 125 0.21 35.546 ± 0.103 
5 62.5 0.29 49.160 ± 0.118 
6 31.2 0.35 59.346 ± 0.208 
7 15.6 0.41 69.473 ± 0.262 
8 7.8 0.44 74.533 ± 0.292 
9 Cell control 0.59 100.033 ± 0.145 
 
                All values are expressed as mean ± SEM for triplicates values 
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Figure   :   6 Graphical representation of concentration dependent 
Cell viability of MCEKG 
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Anticancer effect of methanolic crude extract of Kancanara guggulu on MCF-7 cell line 
 
                                             Fig.no:7aNormal MCF-7 Cell line 
 
 
 
 
  Fig. no: 7bCytotoxicity -1000µg/ml                               Fig.no. 7cCytotoxicity -250µg/ml 
 
 
 
 
        Fig. no. 7dCytotoxicity -125µg/ml          Fig. no. 7eCytotoxicity -62.5µg/ml 
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6.4 COLUMN CHROMATOGHRAPHY 
6.4.1. ISOLATION OF FLAVONOID FRACTION: 
The methanolic crude extract of Kanchanara Guggulu vati was subjected to column 
chromatography for the isolation of flavonoid fraction and the results are shown in Table 6. 
                       Table 6: Fractions obtained by column chromatography  
 
No. of Fraction 
 
Eluent 
 
Ratio 
 
Colour of 
The fraction 
 
F1-F2 
 
F3-F4 
 
F3-F9 
 
F10-F11 
 
F12-F13 
 
F14-F17 
 
 
Hexane 
 
Ethyl acetate 
 
Ethyl acetate: Methanol 
 
Methanol: Ethyl acetate 
 
Methanol: Ethyl acetate 
 
Methanol: Ethyl acetate 
 
 
100 
 
100 
 
80:20 
 
50:50 
 
50:50 
 
50:50 
 
No 
 
yellow 
 
Light yellow 
 
Dark brown 
 
Light brown 
 
No 
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6.4.2. CHARACTERIZATION OF ISOLATED FLAVONOID FRACTION: 
Thin layer chromatography: 
The different fractions obtained from column chromatography are showing different 
retention factor values. Among the various fractionsno: 10 & 11
th
 determined as best fraction 
by UV flourescense with three spots. The Rfvalues for each fraction are shown in Table 7. 
                                   Table 7: Rf values for isolated fraction 
 
Fraction 
 
Solvent system 
 
No. of 
spots 
 
 
Rf value 
 
No. 10 
 
Toluene: Ethyl acetate: Methanol 
(1: 0.5: 0.5) 
 
3 
0.717, 0.782, 0.847 
 
No. 11 
 
3 
 
0.777, 0.755, 0.844 
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                      Figure : 8    IR spectrum of isolated fraction 
 
                                               Table 8: IR data for isolated fraction 
 
Wave number 
 
Comments 
 
3406-3200 cm
-1
 
2927-2854 cm
-1
 
1602-1514 cm
-1 
1707-1634 cm
-1
 
863-721 cm
-1 
 
Phenolic OH 
Ar C-H str 
Ar C=C str 
Keto group str (C=O) 
Ar C-H bending 
 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 450.0
0.0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100.0
cm-1
%T 
11
3406
2927
2854
1707
1634
1602 1514
1455
1381
1250
1162
1127
1076
1036
928
848
721
655
608
466
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Figure    :   9    Gas Chromatography for isolated fraction 
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Figure    : 10    Mass spectrum for isolated fraction 
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6.5 MTT ASSAY FOR IFFKG 
MTT assay were conducted using isolated flavonoid fraction (no. 11) by column 
chromatography and the results are shown in Table 9.& Figure 11-14. 
 
                       Table 9:  IC50 value and Percentage viability of IFFKG 
 
 
S.no 
 
Concentration 
(µg/ml) 
 
Absorbance 
 
Cell viability (%) 
 
IC50  value 
 
1 
 
1000 
 
0.127 
13.433 ± 0.292 
38.68 
2 500 0.203 21.320 ± 0.195 
3 250 0.283 29.600 ± 0.187 
4 125 0.352 36.693 ± 0.269 
5 62.5 0.426 36.203 ± 0.289 
6 31.2 0.497 52.196 ± 0.265 
7 15.6 0.583 60.886 ± 0.596 
8 7.8 0.672 70.566 ± 0.228 
9 Cell control 0.954 99. 793 ± 0.400 
 
All values are expressed as mean ±SEM values for triplicate values 
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Figure: 11 Graphical representation of concentration dependent cell viability of IFFKG 
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                                     Anticancer effect of IFFKG on MCF-7 cell line  
 
Fig. no: 12a Normal MCF7 Cell line 
 
 
 
 
 
Fig. no12b Cytotoxicity 1000µg/ml   Fig. no 12c Cytotoxicity 31.2µg/ml 
                                           
 
 
 
                                           Fig.no 12d Cytotoxicity 7.8µg/ml 
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Figure   : 13 Percentage cell viability of IFFKG Vs MCEKG 
 
Figure : 14  Percentage cell viability of 5 – FU Vs IFFKG Vs MCEKG 
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6.6. DNA FRAGMENTATION 
     The extraction of DNA from the control MCF-7 cells as well as from the treated cells with 
5-FU and flavonoid extract were carried out and the results are shown in Figure 15 & 16. 
 
Marker       control           5-FU 
                                     Figure   :  15 Fragmentation of DNA 
 
Marker    Control   IFFKG 
Figure   : 16   Fragmentation of DNA 
 
 
 
 
 
 
 
 
 
 
1 2 3 
 
1 2 3 
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7. DISCUSSION 
Breast cancer is malignant neoplasm of breast tissue.  It is most commonly occurring 
cancer in females. It accounts for 23% of newly occurring cancer worldwide and represents 
13.7% of all cancer death. In both developed and developing countries, breast cancer mortality 
and incidence rates are projected to rising continuously.
[10]
 With increase in mortality rates 
among patients suffering from cancer with limited success being achieved in clinical therapies 
including radiation, chemotherapy, immune modulation and surgery in treating cancer patients, 
there arises a need for new way for cancer treatment.
[95] 
           Nature has given us a variety of useful medication to cure number of diseases. The role of 
natural products as a source of remedies for diseases can be dated back to 1500 BC. It has been 
estimated that 60% of the approved drugs used for treating cancer are derived from natural 
sources. After long folk practices, many Indian medicines have been screened and they are used 
for treating and preventing various chronic disorders like cardiovascular diseases and cancer.
 
Ayurvedic medicines were found to be able to cure diseases better, which were 
previously not amenable to Western practices. Traditional Indian medicine with its evolution 
through centuries has always fascinated practitioners and researchers for its applications in a 
cancer treatment on a scientifically proven research background. Herbal drugs consisting of 
multiple herb each possessing tremendous potential for a cancer cure are commonly used in 
Ayurveda.
 [1] 
Kanchanara guggulu vati is an ayurvedic polyherbal formulation which consisting of 
twelve herbs and it is extensively used for the treatment of hypothyroidism and obesity, PCOS, 
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tumor, skin diseases and also used as immune system booster, appetite stimulant, and 
detoxifier.
[19] 
            The phytochemical analysis of methanolic crude extract from Kanchanara guggulu vati 
revealed that the presence of flavonoids, phenols, tannins, and alkaloids. 
7.1 Antioxidant activity 
The antioxidant activity of methanolic crude extracts from Kanchanara guggulu vati was 
evaluated. The largest capacity to neutralize DPPH radicals was found for methanolic crude 
extract, which neutralizes 50% of free radicals at the concentration of 70.98µg/ml (Table.3). In 
comparison to the IC 50 value of ascorbic acid (35.57µg/ml), methanolic crude extract from 
Kanchanara guggulu manifested the strongest capacity for neutralization of DPPH radicals. The 
phytochemical analysis showed that the presence of flavonoid, phenolic compound and tannins 
.Phenols, and flavonoids are very important plant constituents because of their scavenging 
activity on free radicals. Therefore, the presence flavonoids, and phenols may contribute directly 
to their antioxidant activity.  
7.2 MTT assay for methanolic crude extract of Kanchanar guggulu vati 
In-vitro cytotoxicity activity was carried out in human breast cancer cell line (MCF-7) 
with the methanolic crude extract and 5-Flurouracil standard drug. The IC50 values for 5-
Flurouracil and MCEKG was found to be 15.96µg/ml (Table.4), 55.26µg/ml (Table.5) 
respectively. Cells treated with higher concentration showed significant decrease in number of 
viable cells. 
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7.3 Isolation of flavonoid fraction by column chromatography 
The methanolic crude extract from Kanchanara guggulu was subjected to isolation of 
flavonoid fraction by column chromatography. The sample was loaded  and eluted using various 
extract like hexane (100%), ethyl acetate (100%), ethyl acetate: methanol (80:20), and ethyl 
acetate: methanol (50:50).  
             Totally sixteen fractions were collected and each fractions were subjected to TLC 
studies. Individual fractions was investigated for the presence of flavonoid by comparing with 
standard quercetin. 
   Among the various fractions fraction, no: 10 & 11 were determined as best fraction with 
three yellowish green spots.  The Rf value for 10
th
 fraction was found to be 0.717, 0.782, 0.847 
and for 11
th
 fraction was found to be 0.777, 0.755, 0.844 (Table.7).  The two fractions were 
chosen for further characterization studies. 
7.4 Characterization of isolated fraction 
The two fractions (10 &11) were analyzed by FT-IR spectroscopy and GC-MS analyzer. 
From the data 11
th
 fraction was found to be contains flavonoid (quercetin) with 20.92 % 
(figure.9) purity and the molecular weight was found to be 302.11 (figure.10), and this fraction 
was selected for further studies. 
7.5 MTT assay for flavonoid fraction obtained by column chomatography 
The flavonoid fraction was subjected to MTT assay against human breast cancer cell line 
(MCF-7) and the IC50 value was found to be 38.68µg/ml (Table.9), cells treated with higher 
concentration showed significant decrease in number of viable cells. 
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When compared the cytotoxicity effect with methanolic crude extract the flavonoid rich 
fractions showed the higher cytotoxicity effect with lower IC50 value, percentage inhibition was 
expressed with the help of graph.  
          This may probably due to the presence of phytochemical flavonoids, because flavonoids 
have been inhibits the proliferation in cultured cells, the molecular mechanisms of anti-
proliferation may involve the pro-oxidant process that causes tumor promotion, also by inhibit 
ornithine decarboxylase induced by tumor promoters and thus cause a subsequent decrease in 
polyamine and inhibition of DNA/protein synthesis.
[16] 
7.6 DNA fragmentation 
DNA fragmentation as one of the hallmark of apoptosis was evaluated by gel 
electrophoresis method. After 48 hours of exposure of MCF-7 cells to IC50 concentration of 
flavonoid fraction of Kanchanara guggulu vati and 5- FU the fragmentation was observed. The 
untreated cells did not show any fragmentation, which proves apoptosis induced by flavonoid 
fraction of Kanchanara guggulu vati by fragmenting the DNA (Figure15, 16).    
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8. CONCLUSION 
From present study it may be concluded that, 
 The phyto chemical investigation revealed the presence of flavonoids, phenolic 
acids, alkaloids, fixed oils& fatty acids, and steroids, carbohydrates and saponins. 
 MTT assay was carried out for methanolic crude extract of Kanchanara guggulu, 
which inhibited 50% of cell growth at the concentration of 55.26µg/ml. 
 The flavonoid fraction was isolated by column chromatography and it was 
characterized by FT-IR and GC-MS. 
 The isolated flavonoid fraction was subjected to MTT assay, which inhibited 50% 
of cell growth at the concentration of 38.68µg/ml. 
 DNA fragmentation was observed in flavonoid fraction treated cells, which 
confirmed the ability of Kanchanara guggulu induced apoptotic cell death. 
The cytotoxicity activity, apoptotic studies which were carried out in extract of 
Kanchanara guggulu using in-vitro methods can be confirmed with in-vivo animal models for the 
future perspective.    
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